<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">27140856</PMID>
      <DateCompleted>
        <Year>2017</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1759-507X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>12</Volume>
            <Issue>7</Issue>
            <PubDate>
              <Year>2016</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nature reviews. Nephrology</Title>
          <ISOAbbreviation>Nat Rev Nephrol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog.</ArticleTitle>
        <Pagination>
          <StartPage>426</StartPage>
          <EndPage>439</EndPage>
          <MedlinePgn>426-39</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/nrneph.2016.54</ELocationID>
        <Abstract>
          <AbstractText>Kidney fibrosis is a common histological manifestation of functional decline in the kidney. Fibrosis is a reactive process that develops in response to excessive epithelial injury and inflammation, leading to myofibroblast activation and an accumulation of extracellular matrix. Here, we describe how three key developmental signalling pathways - Notch, Wnt and Hedgehog (Hh) - are reactivated in response to kidney injury and contribute to the fibrotic response. Although transient activation of these pathways is needed for repair of injured tissue, their sustained activation is thought to promote fibrosis. Excessive Wnt and Notch expression prohibit epithelial differentiation, whereas increased Wnt and Hh expression induce fibroblast proliferation and myofibroblastic transdifferentiation. Notch, Wnt and Hh are fundamentally different signalling pathways, but their choreographed activation seems to be just as important for fibrosis as it is for embryonic kidney development. Decreasing the activity of Notch, Wnt or Hh signalling could potentially provide a new therapeutic strategy to ameliorate the development of fibrosis in chronic kidney disease.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Edeling</LastName>
            <ForeName>Maria</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Renal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 415 Curie Boulevard, 415 Clinical Research Building, Philadelphia, Pennsylvania 19104, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Nephrology, Internal Medicine D, University Hospital Albert-Schweitzer-Straße 33, Münster 48149, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ragi</LastName>
            <ForeName>Grace</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Renal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 415 Curie Boulevard, 415 Clinical Research Building, Philadelphia, Pennsylvania 19104, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Shizheng</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Renal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 415 Curie Boulevard, 415 Clinical Research Building, Philadelphia, Pennsylvania 19104, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pavenstädt</LastName>
            <ForeName>Hermann</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Nephrology, Internal Medicine D, University Hospital Albert-Schweitzer-Straße 33, Münster 48149, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Susztak</LastName>
            <ForeName>Katalin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Renal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 415 Curie Boulevard, 415 Clinical Research Building, Philadelphia, Pennsylvania 19104, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>DP3 DK108220</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK076077</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK087635</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK105821</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2016</Year>
          <Month>05</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Nat Rev Nephrol</MedlineTA>
        <NlmUniqueID>101500081</NlmUniqueID>
        <ISSNLinking>1759-5061</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053823">Hedgehog Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051880">Receptors, Notch</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053823" MajorTopicYN="N">Hedgehog Proteins</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050199" MajorTopicYN="N">Podocytes</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051880" MajorTopicYN="N">Receptors, Notch</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060449" MajorTopicYN="N">Wnt Signaling Pathway</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement><b>Competing interests</b>. The Susztaklab received research support from Boehringer Ingelheim, Biogen and Lilly.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2017</Year>
          <Month>5</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">27140856</ArticleId>
        <ArticleId IdType="mid">NIHMS876485</ArticleId>
        <ArticleId IdType="pmc">PMC5529143</ArticleId>
        <ArticleId IdType="doi">10.1038/nrneph.2016.54</ArticleId>
        <ArticleId IdType="pii">nrneph.2016.54</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Jha V. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260–272. doi: 10.1016/S0140-6736(13)60687-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(13)60687-X</ArticleId>
            <ArticleId IdType="pubmed">23727169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 2006;69:213–217. doi: 10.1038/sj.ki.5000054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.ki.5000054</ArticleId>
            <ArticleId IdType="pubmed">16408108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tonelli M, et al.  Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17:2034–2047. doi: 10.1681/ASN.2005101085.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2005101085</ArticleId>
            <ArticleId IdType="pubmed">16738019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reidy K, Kang HM, Hostetter T, Susztak K. Molecular mechanisms of diabetic kidney disease. J Clin Invest. 2014;124:2333–2340. doi: 10.1172/JCI72271.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI72271</ArticleId>
            <ArticleId IdType="pmc">PMC4089448</ArticleId>
            <ArticleId IdType="pubmed">24892707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duffield JS. Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest. 2014;124:2299–2306. doi: 10.1172/JCI72267.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI72267</ArticleId>
            <ArticleId IdType="pmc">PMC4038570</ArticleId>
            <ArticleId IdType="pubmed">24892703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol. 2011;7:684–696. doi: 10.1038/nrneph.2011.149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrneph.2011.149</ArticleId>
            <ArticleId IdType="pmc">PMC4520424</ArticleId>
            <ArticleId IdType="pubmed">22009250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaissling B, Lehir M, Kriz W. Renal epithelial injury and fibrosis. Biochim Biophys Acta. 2013;1832:931–939. doi: 10.1016/j.bbadis.2013.02.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbadis.2013.02.010</ArticleId>
            <ArticleId IdType="pubmed">23466594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grgic I, Duffield JS, Humphreys BD. The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol. 2012;27:183–193. doi: 10.1007/s00467-011-1772-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00467-011-1772-6</ArticleId>
            <ArticleId IdType="pmc">PMC3116994</ArticleId>
            <ArticleId IdType="pubmed">21311912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Humphreys BD, et al.  Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol. 2010;176:85–97. doi: 10.2353/ajpath.2010.090517.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2353/ajpath.2010.090517</ArticleId>
            <ArticleId IdType="pmc">PMC2797872</ArticleId>
            <ArticleId IdType="pubmed">20008127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woroniecka KI, et al.  Transcriptome analysis of human diabetic kidney disease. Diabetes. 2011;60:2354–2369. doi: 10.2337/db10-1181.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db10-1181</ArticleId>
            <ArticleId IdType="pmc">PMC3161334</ArticleId>
            <ArticleId IdType="pubmed">21752957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Susztak K, Raff AC, Schiffer M, Bottinger EP. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes. 2006;55:225–233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16380497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huber TB, et al.  Emerging role of autophagy in kidney function, diseases and aging. Autophagy. 2012;8:1009–1031. doi: 10.4161/auto.19821.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/auto.19821</ArticleId>
            <ArticleId IdType="pmc">PMC3429540</ArticleId>
            <ArticleId IdType="pubmed">22692002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lieberthal W, Levine JS. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am J Physiol. 1996;271:F477–488.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8853409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ueda N, Kaushal GP, Shah SV. Recent advances in understanding mechanisms of renal tubular injury. Adv Ren Replace Ther. 1997;4:17–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9113237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lieberthal W, Koh JS, Levine JS. Necrosis and apoptosis in acute renal failure. Semin Nephrol. 1998;18:505–518.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9754603</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petermann A, Floege J. Podocyte damage resulting in podocyturia: a potential diagnostic marker to assess glomerular disease activity. Nephron Clin Pract. 2007;106:c61–66. doi: 10.1159/000101799.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000101799</ArticleId>
            <ArticleId IdType="pubmed">17570931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest. 2011;121:4210–4221. doi: 10.1172/JCI45161.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI45161</ArticleId>
            <ArticleId IdType="pmc">PMC3204829</ArticleId>
            <ArticleId IdType="pubmed">22045571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hakroush S, et al.  Extensive podocyte loss triggers a rapid parietal epithelial cell response. J Am Soc Nephrol. 2014;25:927–938. doi: 10.1681/ASN.2013070687.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2013070687</ArticleId>
            <ArticleId IdType="pmc">PMC4005306</ArticleId>
            <ArticleId IdType="pubmed">24335975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eng DG, et al.  Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis. Kidney Int. 2015;88:999–1012. doi: 10.1038/ki.2015.152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2015.152</ArticleId>
            <ArticleId IdType="pmc">PMC4654724</ArticleId>
            <ArticleId IdType="pubmed">25993321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wharram BL, et al.  Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol. 2005;16:2941–2952. doi: 10.1681/ASN.2005010055.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2005010055</ArticleId>
            <ArticleId IdType="pubmed">16107576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rutkowski JM, et al.  Adiponectin promotes functional recovery after podocyte ablation. J Am Soc Nephrol. 2013;24:268–282. doi: 10.1681/ASN.2012040414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2012040414</ArticleId>
            <ArticleId IdType="pmc">PMC3559480</ArticleId>
            <ArticleId IdType="pubmed">23334396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inoki K, et al.  mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest. 2011;121:2181–2196. doi: 10.1172/JCI44771.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI44771</ArticleId>
            <ArticleId IdType="pmc">PMC3104745</ArticleId>
            <ArticleId IdType="pubmed">21606597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Godel M, et al.  Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest. 2011;121:2197–2209. doi: 10.1172/JCI44774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI44774</ArticleId>
            <ArticleId IdType="pmc">PMC3104746</ArticleId>
            <ArticleId IdType="pubmed">21606591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wiggins JE, et al.  Podocyte hypertrophy, “adaptation,” and “decompensation” associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol. 2005;16:2953–2966. doi: 10.1681/ASN.2005050488.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2005050488</ArticleId>
            <ArticleId IdType="pubmed">16120818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pagtalunan ME, et al.  Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest. 1997;99:342–348. doi: 10.1172/JCI119163.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI119163</ArticleId>
            <ArticleId IdType="pmc">PMC507802</ArticleId>
            <ArticleId IdType="pubmed">9006003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes. 2005;54:1626–1634.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15919782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dimke H, et al.  Tubulovascular Cross-Talk by Vascular Endothelial Growth Factor A Maintains Peritubular Microvasculature in Kidney. J Am Soc Nephrol. 2014 doi: 10.1681/ASN.2014010060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2014010060</ArticleId>
            <ArticleId IdType="pmc">PMC4413754</ArticleId>
            <ArticleId IdType="pubmed">25385849</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol. 2005;15:599–607. doi: 10.1016/j.tcb.2005.09.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tcb.2005.09.002</ArticleId>
            <ArticleId IdType="pubmed">16202600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gu L, et al.  Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy. AIDS. 2013;27:1091–1098. doi: 10.1097/QAD.0b013e32835f1ea1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/QAD.0b013e32835f1ea1</ArticleId>
            <ArticleId IdType="pmc">PMC3918880</ArticleId>
            <ArticleId IdType="pubmed">23343908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dai Y, et al.  Podocyte-specific deletion of signal transducer and activator of transcription 3 attenuates nephrotoxic serum-induced glomerulonephritis. Kidney Int. 2013;84:950–961. doi: 10.1038/ki.2013.197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2013.197</ArticleId>
            <ArticleId IdType="pmc">PMC3797218</ArticleId>
            <ArticleId IdType="pubmed">23842188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 2001;107:7–11. doi: 10.1172/JCI11830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI11830</ArticleId>
            <ArticleId IdType="pmc">PMC198552</ArticleId>
            <ArticleId IdType="pubmed">11134171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng XM, Nikolic-Paterson DJ, Lan HY. Inflammatory processes in renal fibrosis. Nat Rev Nephrol. 2014;10:493–503. doi: 10.1038/nrneph.2014.114.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrneph.2014.114</ArticleId>
            <ArticleId IdType="pubmed">24981817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar D, Singla SK, Puri V, Puri S. The restrained expression of NF-kB in renal tissue ameliorates folic acid induced acute kidney injury in mice. PLoS One. 2015;10:e115947. doi: 10.1371/journal.pone.0115947.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0115947</ArticleId>
            <ArticleId IdType="pmc">PMC4283964</ArticleId>
            <ArticleId IdType="pubmed">25559736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okabe C, et al.  NF-kappaB activation mediates crystal translocation and interstitial inflammation in adenine overload nephropathy. Am J Physiol Renal Physiol. 2013;305:F155–163. doi: 10.1152/ajprenal.00491.2012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.00491.2012</ArticleId>
            <ArticleId IdType="pubmed">23657853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yukawa K, et al.  STAT6 deficiency inhibits tubulointerstitial fibrosis in obstructive nephropathy. Int J Mol Med. 2005;15:225–230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15647835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedman SL, Sheppard D, Duffield JS, Violette S. Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med. 2013;5:167sr161. doi: 10.1126/scitranslmed.3004700.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scitranslmed.3004700</ArticleId>
            <ArticleId IdType="pubmed">23303606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meran S, Steadman R. Fibroblasts and myofibroblasts in renal fibrosis. Int J Exp Pathol. 2011;92:158–167. doi: 10.1111/j.1365-2613.2011.00764.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2613.2011.00764.x</ArticleId>
            <ArticleId IdType="pmc">PMC3101489</ArticleId>
            <ArticleId IdType="pubmed">21355940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu B, Phan SH. Myofibroblasts. Curr Opin Rheumatol. 2013;25:71–77. doi: 10.1097/BOR.0b013e32835b1352.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/BOR.0b013e32835b1352</ArticleId>
            <ArticleId IdType="pmc">PMC4007118</ArticleId>
            <ArticleId IdType="pubmed">23114586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kendall RT, Feghali-Bostwick CA. Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol. 2014;5:123. doi: 10.3389/fphar.2014.00123.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2014.00123</ArticleId>
            <ArticleId IdType="pmc">PMC4034148</ArticleId>
            <ArticleId IdType="pubmed">24904424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klingberg F, Hinz B, White ES. The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol. 2013;229:298–309. doi: 10.1002/path.4104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/path.4104</ArticleId>
            <ArticleId IdType="pmc">PMC4005341</ArticleId>
            <ArticleId IdType="pubmed">22996908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wight TN, Potter-Perigo S. The extracellular matrix: an active or passive player in fibrosis. Am J Physiol Gastrointest Liver Physiol. 2011;301:G950–955. doi: 10.1152/ajpgi.00132.2011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpgi.00132.2011</ArticleId>
            <ArticleId IdType="pmc">PMC3233785</ArticleId>
            <ArticleId IdType="pubmed">21512158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olsen AL, et al.  Hepatic stellate cells require a stiff environment for myofibroblastic differentiation. Am J Physiol Gastrointest Liver Physiol. 2011;301:G110–118. doi: 10.1152/ajpgi.00412.2010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpgi.00412.2010</ArticleId>
            <ArticleId IdType="pmc">PMC3129929</ArticleId>
            <ArticleId IdType="pubmed">21527725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Urban ML, Manenti L, Vaglio A. Fibrosis–A Common Pathway to Organ Injury and Failure. N Engl J Med. 2015;373:95–96. doi: 10.1056/NEJMc1504848#SA2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc1504848#SA2</ArticleId>
            <ArticleId IdType="pubmed">26132961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest. 2007;117:524–529. doi: 10.1172/JCI31487.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI31487</ArticleId>
            <ArticleId IdType="pmc">PMC1804380</ArticleId>
            <ArticleId IdType="pubmed">17332879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lavoz C, et al.  Angiotensin II contributes to renal fibrosis independently of Notch pathway activation. PLoS One. 2012;7:e40490. doi: 10.1371/journal.pone.0040490.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0040490</ArticleId>
            <ArticleId IdType="pmc">PMC3392235</ArticleId>
            <ArticleId IdType="pubmed">22792351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boor P, Floege J. Chronic kidney disease growth factors in renal fibrosis. Clin Exp Pharmacol Physiol. 2011;38:441–450. doi: 10.1111/j.1440-1681.2011.05487.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1440-1681.2011.05487.x</ArticleId>
            <ArticleId IdType="pubmed">21276040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chuang PY, Menon MC, He JC. Molecular targets for treatment of kidney fibrosis. J Mol Med (Berl) 2013;91:549–559. doi: 10.1007/s00109-012-0983-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00109-012-0983-z</ArticleId>
            <ArticleId IdType="pmc">PMC3594378</ArticleId>
            <ArticleId IdType="pubmed">23179685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shull MM, et al.  Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992;359:693–699. doi: 10.1038/359693a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/359693a0</ArticleId>
            <ArticleId IdType="pmc">PMC3889166</ArticleId>
            <ArticleId IdType="pubmed">1436033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kulkarni AB, et al.  Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A. 1993;90:770–774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC45747</ArticleId>
            <ArticleId IdType="pubmed">8421714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai EC. Notch signaling: control of cell communication and cell fate. Development. 2004;131:965–973. doi: 10.1242/dev.01074.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.01074</ArticleId>
            <ArticleId IdType="pubmed">14973298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ilagan MX, Lim S, Fulbright M, Piwnica-Worms D, Kopan R. Real-time imaging of notch activation with a luciferase complementation-based reporter. Sci Signal. 2011;4:rs7. doi: 10.1126/scisignal.2001656.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scisignal.2001656</ArticleId>
            <ArticleId IdType="pmc">PMC3387985</ArticleId>
            <ArticleId IdType="pubmed">21775282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137:216–233. doi: 10.1016/j.cell.2009.03.045.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2009.03.045</ArticleId>
            <ArticleId IdType="pmc">PMC2827930</ArticleId>
            <ArticleId IdType="pubmed">19379690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sirin Y, Susztak K. Notch in the kidney: development and disease. J Pathol. 2012;226:394–403. doi: 10.1002/path.2967.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/path.2967</ArticleId>
            <ArticleId IdType="pmc">PMC3677191</ArticleId>
            <ArticleId IdType="pubmed">21952830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Penton AL, Leonard LD, Spinner NB. Notch signaling in human development and disease. Semin Cell Dev Biol. 2012;23:450–457. doi: 10.1016/j.semcdb.2012.01.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semcdb.2012.01.010</ArticleId>
            <ArticleId IdType="pmc">PMC3638987</ArticleId>
            <ArticleId IdType="pubmed">22306179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng HT, et al.  Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development. 2007;134:801–811. doi: 10.1242/dev.02773.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.02773</ArticleId>
            <ArticleId IdType="pmc">PMC2613851</ArticleId>
            <ArticleId IdType="pubmed">17229764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujimura S, Jiang Q, Kobayashi C, Nishinakamura R. Notch2 activation in the embryonic kidney depletes nephron progenitors. J Am Soc Nephrol. 2010;21:803–810. doi: 10.1681/ASN.2009040353.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2009040353</ArticleId>
            <ArticleId IdType="pmc">PMC2865736</ArticleId>
            <ArticleId IdType="pubmed">20299358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Djudjaj S, et al.  Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury. J Pathol. 2012;228:286–299. doi: 10.1002/path.4076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/path.4076</ArticleId>
            <ArticleId IdType="pubmed">22806125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma S, Sirin Y, Susztak K. The story of Notch and chronic kidney disease. Curr Opin Nephrol Hypertens. 2011;20:56–61. doi: 10.1097/MNH.0b013e3283414c88.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MNH.0b013e3283414c88</ArticleId>
            <ArticleId IdType="pmc">PMC3164509</ArticleId>
            <ArticleId IdType="pubmed">21088575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carulli AJ, et al.  Notch receptor regulation of intestinal stem cell homeostasis and crypt regeneration. Dev Biol. 2015;402:98–108. doi: 10.1016/j.ydbio.2015.03.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ydbio.2015.03.012</ArticleId>
            <ArticleId IdType="pmc">PMC4433599</ArticleId>
            <ArticleId IdType="pubmed">25835502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barker N, et al.  Lgr5(+ve) stem/progenitor cells contribute to nephron formation during kidney development. Cell Rep. 2012;2:540–552. doi: 10.1016/j.celrep.2012.08.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2012.08.018</ArticleId>
            <ArticleId IdType="pubmed">22999937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pleniceanu O, Harari-Steinberg O, Dekel B. Concise review: Kidney stem/progenitor cells: differentiate, sort out, or reprogram. Stem Cells. 2010;28:1649–1660. doi: 10.1002/stem.486.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/stem.486</ArticleId>
            <ArticleId IdType="pmc">PMC2996087</ArticleId>
            <ArticleId IdType="pubmed">20652959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar S, et al.  Sox9 Activation Highlights a Cellular Pathway of Renal Repair in the Acutely Injured Mammalian Kidney. Cell Rep. 2015;12:1325–1338. doi: 10.1016/j.celrep.2015.07.034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2015.07.034</ArticleId>
            <ArticleId IdType="pubmed">26279573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reginensi A, et al.  SOX9 controls epithelial branching by activating RET effector genes during kidney development. Hum Mol Genet. 2011;20:1143–1153. doi: 10.1093/hmg/ddq558.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddq558</ArticleId>
            <ArticleId IdType="pmc">PMC3809456</ArticleId>
            <ArticleId IdType="pubmed">21212101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang HM, et al.  Sox9-Positive Progenitor Cells Play a Key Role in Renal Tubule Epithelial Regeneration in Mice. Cell Rep. 2016;14:861–871. doi: 10.1016/j.celrep.2015.12.071.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2015.12.071</ArticleId>
            <ArticleId IdType="pmc">PMC4854207</ArticleId>
            <ArticleId IdType="pubmed">26776520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomez RA, Belyea B, Medrano S, Pentz ES, Sequeira-Lopez ML. Fate and plasticity of renin precursors in development and disease. Pediatr Nephrol. 2014;29:721–726. doi: 10.1007/s00467-013-2688-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00467-013-2688-0</ArticleId>
            <ArticleId IdType="pmc">PMC3999616</ArticleId>
            <ArticleId IdType="pubmed">24337407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bussolati B, et al.  Isolation of renal progenitor cells from adult human kidney. Am J Pathol. 2005;166(10):545–555. 62276–6. doi: 10.1016/S0002-9440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0002-9440</ArticleId>
            <ArticleId IdType="pmc">PMC1602314</ArticleId>
            <ArticleId IdType="pubmed">15681837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J, Chen JK, Conway EM, Harris RC. Survivin mediates renal proximal tubule recovery from AKI. J Am Soc Nephrol. 2013;24:2023–2033. doi: 10.1681/ASN.2013010076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2013010076</ArticleId>
            <ArticleId IdType="pmc">PMC3839548</ArticleId>
            <ArticleId IdType="pubmed">23949800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang R, Zhou Q, Veeraragoo P, Yu H, Xiao Z. Notch2/Hes-1 pathway plays an important role in renal ischemia and reperfusion injury-associated inflammation and apoptosis and the gamma-secretase inhibitor DAPT has a nephroprotective effect. Ren Fail. 2011;33:207–216. doi: 10.3109/0886022X.2011.553979.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/0886022X.2011.553979</ArticleId>
            <ArticleId IdType="pubmed">21332343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sorensen-Zender I, et al.  Renal tubular Notch signaling triggers a prosenescent state after acute kidney injury. Am J Physiol Renal Physiol. 2014;306:F907–915. doi: 10.1152/ajprenal.00030.2014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.00030.2014</ArticleId>
            <ArticleId IdType="pubmed">24573392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murea M, et al.  Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. Kidney Int. 2010;78:514–522. doi: 10.1038/ki.2010.172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2010.172</ArticleId>
            <ArticleId IdType="pmc">PMC3164583</ArticleId>
            <ArticleId IdType="pubmed">20531454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bielesz B, et al.  Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest. 2010;120:4040–4054. doi: 10.1172/JCI43025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI43025</ArticleId>
            <ArticleId IdType="pmc">PMC2964979</ArticleId>
            <ArticleId IdType="pubmed">20978353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, Li Y, Kong D, Sarkar FH. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Curr Drug Targets. 2010;11:745–751.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3084452</ArticleId>
            <ArticleId IdType="pubmed">20041844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saad S, Stanners SR, Yong R, Tang O, Pollock CA. Notch mediated epithelial to mesenchymal transformation is associated with increased expression of the Snail transcription factor. Int J Biochem Cell Biol. 2010;42:1115–1122. doi: 10.1016/j.biocel.2010.03.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biocel.2010.03.016</ArticleId>
            <ArticleId IdType="pubmed">20348013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grande MT, et al.  Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat Med. 2015;21:989–997. doi: 10.1038/nm.3901.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.3901</ArticleId>
            <ArticleId IdType="pubmed">26236989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lovisa S, et al.  Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat Med. 2015;21:998–1009. doi: 10.1038/nm.3902.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.3902</ArticleId>
            <ArticleId IdType="pmc">PMC4587560</ArticleId>
            <ArticleId IdType="pubmed">26236991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lasagni L, et al.  Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. Stem Cells. 2010;28:1674–1685. doi: 10.1002/stem.492.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/stem.492</ArticleId>
            <ArticleId IdType="pmc">PMC2996085</ArticleId>
            <ArticleId IdType="pubmed">20680961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen L, Al-Awqati Q. Segmental expression of Notch and Hairy genes in nephrogenesis. Am J Physiol Renal Physiol. 2005;288:F939–952. doi: 10.1152/ajprenal.00369.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.00369.2004</ArticleId>
            <ArticleId IdType="pubmed">15821257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barak H, Surendran K, Boyle SC. The role of Notch signaling in kidney development and disease. Adv Exp Med Biol. 2012;727:99–113. doi: 10.1007/978-1-4614-0899-4_8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-4614-0899-4_8</ArticleId>
            <ArticleId IdType="pubmed">22399342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bielefeld KA, Amini-Nik S, Alman BA. Cutaneous wound healing: recruiting developmental pathways for regeneration. Cell Mol Life Sci. 2013;70:2059–2081. doi: 10.1007/s00018-012-1152-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-012-1152-9</ArticleId>
            <ArticleId IdType="pmc">PMC3663196</ArticleId>
            <ArticleId IdType="pubmed">23052205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao Z, et al.  The Notch gamma-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-beta/Smad2/3 signaling pathway activation. Int J Biochem Cell Biol. 2014;55:65–71. doi: 10.1016/j.biocel.2014.08.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biocel.2014.08.009</ArticleId>
            <ArticleId IdType="pubmed">25150830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takebe N, Harris PJ, Warren RQ, Ivy SP. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol. 2011;8:97–106. doi: 10.1038/nrclinonc.2010.196.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrclinonc.2010.196</ArticleId>
            <ArticleId IdType="pubmed">21151206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayward P, Kalmar T, Arias AM. Wnt/Notch signalling and information processing during development. Development. 2008;135:411–424. doi: 10.1242/dev.000505.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.000505</ArticleId>
            <ArticleId IdType="pubmed">18192283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niranjan T, et al.  The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med. 2008;14:290–298. doi: 10.1038/nm1731.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm1731</ArticleId>
            <ArticleId IdType="pubmed">18311147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niranjan T, Murea M, Susztak K. The pathogenic role of Notch activation in podocytes. Nephron Exp Nephrol. 2009;111:e73–79. doi: 10.1159/000209207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000209207</ArticleId>
            <ArticleId IdType="pmc">PMC2851161</ArticleId>
            <ArticleId IdType="pubmed">19293596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin CL, et al.  Modulation of notch-1 signaling alleviates vascular endothelial growth factor-mediated diabetic nephropathy. Diabetes. 2010;59:1915–1925. doi: 10.2337/db09-0663.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db09-0663</ArticleId>
            <ArticleId IdType="pmc">PMC2911050</ArticleId>
            <ArticleId IdType="pubmed">20522599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanaka E, et al.  Notch2 activation ameliorates nephrosis. Nat Commun. 2014;5:3296. doi: 10.1038/ncomms4296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms4296</ArticleId>
            <ArticleId IdType="pubmed">24526233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arking DE, et al.  Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization. Nat Genet. 2014;46:826–836. doi: 10.1038/ng.3014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng.3014</ArticleId>
            <ArticleId IdType="pmc">PMC4124521</ArticleId>
            <ArticleId IdType="pubmed">24952745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sweetwyne MT, et al.  Notch1 and Notch2 in Podocytes Play Differential Roles During Diabetic Nephropathy Development. Diabetes. 2015;64:4099–4111. doi: 10.2337/db15-0260.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db15-0260</ArticleId>
            <ArticleId IdType="pmc">PMC4657584</ArticleId>
            <ArticleId IdType="pubmed">26293507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El Machhour F, Keuylian Z, Kavvadas P, Dussaule JC, Chatziantoniou C. Activation of Notch3 in Glomeruli Promotes the Development of Rapidly Progressive Renal Disease. J Am Soc Nephrol. 2015;26:1561–1575. doi: 10.1681/ASN.2013090968.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2013090968</ArticleId>
            <ArticleId IdType="pmc">PMC4483574</ArticleId>
            <ArticleId IdType="pubmed">25421557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nusse R, Varmus H. Three decades of Wnts: a personal perspective on how a scientific field developed. EMBO J. 2012;31:2670–2684. doi: 10.1038/emboj.2012.146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/emboj.2012.146</ArticleId>
            <ArticleId IdType="pmc">PMC3380217</ArticleId>
            <ArticleId IdType="pubmed">22617420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sokol SY. Spatial and temporal aspects of Wnt signaling and planar cell polarity during vertebrate embryonic development. Semin Cell Dev Biol. 2015;42:78–85. doi: 10.1016/j.semcdb.2015.05.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semcdb.2015.05.002</ArticleId>
            <ArticleId IdType="pmc">PMC4562884</ArticleId>
            <ArticleId IdType="pubmed">25986055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kahn M. Can we safely target the WNT pathway. Nat Rev Drug Discov. 2014;13:513–532. doi: 10.1038/nrd4233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrd4233</ArticleId>
            <ArticleId IdType="pmc">PMC4426976</ArticleId>
            <ArticleId IdType="pubmed">24981364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holland JD, Klaus A, Garratt AN, Birchmeier W. Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol. 2013;25:254–264. doi: 10.1016/j.ceb.2013.01.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ceb.2013.01.004</ArticleId>
            <ArticleId IdType="pubmed">23347562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo Y, Xiao L, Sun L, Liu F. Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. Physiol Res. 2012;61:337–346.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22670697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He X, Semenov M, Tamai K, Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development. 2004;131:1663–1677. doi: 10.1242/dev.01117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.01117</ArticleId>
            <ArticleId IdType="pubmed">15084453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moon RT, Kohn AD, De Ferrari GV, Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet. 2004;5:691–701. doi: 10.1038/nrg1427.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrg1427</ArticleId>
            <ArticleId IdType="pubmed">15372092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boyle SC, Kim M, Valerius MT, McMahon AP, Kopan R. Notch pathway activation can replace the requirement for Wnt4 and Wnt9b in mesenchymal-to-epithelial transition of nephron stem cells. Development. 2011;138:4245–4254. doi: 10.1242/dev.070433.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.070433</ArticleId>
            <ArticleId IdType="pmc">PMC3171224</ArticleId>
            <ArticleId IdType="pubmed">21852398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosenberg SL, Chen S, McLaughlin N, El-Dahr SS. Regulation of kidney development by histone deacetylases. Pediatr Nephrol. 2011;26:1445–1452. doi: 10.1007/s00467-011-1796-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00467-011-1796-y</ArticleId>
            <ArticleId IdType="pmc">PMC3199300</ArticleId>
            <ArticleId IdType="pubmed">21336812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawakami T, Ren S, Duffield JS. Wnt signalling in kidney diseases: dual roles in renal injury and repair. J Pathol. 2013;229:221–231. doi: 10.1002/path.4121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/path.4121</ArticleId>
            <ArticleId IdType="pubmed">23097132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliver JA, Maarouf O, Cheema FH, Martens TP, Al-Awqati Q. The renal papilla is a niche for adult kidney stem cells. J Clin Invest. 2004;114:795–804. doi: 10.1172/JCI20921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI20921</ArticleId>
            <ArticleId IdType="pmc">PMC516259</ArticleId>
            <ArticleId IdType="pubmed">15372103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rinkevich Y, et al.  In vivo clonal analysis reveals lineage-restricted progenitor characteristics in mammalian kidney development, maintenance, and regeneration. Cell Rep. 2014;7:1270–1283. doi: 10.1016/j.celrep.2014.04.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2014.04.018</ArticleId>
            <ArticleId IdType="pmc">PMC4425291</ArticleId>
            <ArticleId IdType="pubmed">24835991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin SL, et al.  Macrophage Wnt7b is critical for kidney repair and regeneration. Proc Natl Acad Sci U S A. 2010;107:4194–4199. doi: 10.1073/pnas.0912228107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0912228107</ArticleId>
            <ArticleId IdType="pmc">PMC2840080</ArticleId>
            <ArticleId IdType="pubmed">20160075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao L, et al.  Sustained Activation of Wnt/beta-Catenin Signaling Drives AKI to CKD Progression. J Am Soc Nephrol. 2015 doi: 10.1681/ASN.2015040449.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2015040449</ArticleId>
            <ArticleId IdType="pmc">PMC4884114</ArticleId>
            <ArticleId IdType="pubmed">26453613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terada Y, et al.  Expression and function of the developmental gene Wnt-4 during experimental acute renal failure in rats. J Am Soc Nephrol. 2003;14:1223–1233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12707392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou D, et al.  Tubule-specific ablation of endogenous beta-catenin aggravates acute kidney injury in mice. Kidney Int. 2012;82:537–547. doi: 10.1038/ki.2012.173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2012.173</ArticleId>
            <ArticleId IdType="pmc">PMC3425732</ArticleId>
            <ArticleId IdType="pubmed">22622501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He W, et al.  Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol. 2009;20:765–776. doi: 10.1681/ASN.2008060566.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2008060566</ArticleId>
            <ArticleId IdType="pmc">PMC2663839</ArticleId>
            <ArticleId IdType="pubmed">19297557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou D, Tan RJ, Zhou L, Li Y, Liu Y. Kidney tubular beta-catenin signaling controls interstitial fibroblast fate via epithelial-mesenchymal communication. Sci Rep. 2013;3:1878. doi: 10.1038/srep01878.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep01878</ArticleId>
            <ArticleId IdType="pmc">PMC3662012</ArticleId>
            <ArticleId IdType="pubmed">23698793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Satoh W, Matsuyama M, Takemura H, Aizawa S, Shimono A. Sfrp1, Sfrp2, and Sfrp5 regulate the Wnt/beta-catenin and the planar cell polarity pathways during early trunk formation in mouse. Genesis. 2008;46:92–103. doi: 10.1002/dvg.20369.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/dvg.20369</ArticleId>
            <ArticleId IdType="pubmed">18257070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuyama M, Nomori A, Nakakuni K, Shimono A, Fukushima M. Secreted Frizzled-related protein 1 (Sfrp1) regulates the progression of renal fibrosis in a mouse model of obstructive nephropathy. J Biol Chem. 2014;289:31526–31533. doi: 10.1074/jbc.M114.584565.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M114.584565</ArticleId>
            <ArticleId IdType="pmc">PMC4223350</ArticleId>
            <ArticleId IdType="pubmed">25253698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xue H, et al.  Disruption of the Dapper3 gene aggravates ureteral obstruction-mediated renal fibrosis by amplifying Wnt/beta-catenin signaling. J Biol Chem. 2013;288:15006–15014. doi: 10.1074/jbc.M113.458448.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M113.458448</ArticleId>
            <ArticleId IdType="pmc">PMC3663521</ArticleId>
            <ArticleId IdType="pubmed">23580654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen B, et al.  Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol. 2009;5:100–107. doi: 10.1038/nchembio.137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nchembio.137</ArticleId>
            <ArticleId IdType="pmc">PMC2628455</ArticleId>
            <ArticleId IdType="pubmed">19125156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palmer HG, et al.  Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol. 2001;154:369–387.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2150773</ArticleId>
            <ArticleId IdType="pubmed">11470825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou L, et al.  Multiple genes of the renin-angiotensin system are novel targets of Wnt/beta-catenin signaling. J Am Soc Nephrol. 2015;26:107–120. doi: 10.1681/ASN.2014010085.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2014010085</ArticleId>
            <ArticleId IdType="pmc">PMC4279741</ArticleId>
            <ArticleId IdType="pubmed">25012166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DiRocco DP, Kobayashi A, Taketo MM, McMahon AP, Humphreys BD. Wnt4/beta-catenin signaling in medullary kidney myofibroblasts. J Am Soc Nephrol. 2013;24:1399–1412. doi: 10.1681/ASN.2012050512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2012050512</ArticleId>
            <ArticleId IdType="pmc">PMC3752942</ArticleId>
            <ArticleId IdType="pubmed">23766539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang P, Cai Y, Soofi A, Dressler GR. Activation of Wnt11 by transforming growth factor-beta drives mesenchymal gene expression through non-canonical Wnt protein signaling in renal epithelial cells. J Biol Chem. 2012;287:21290–21302. doi: 10.1074/jbc.M112.357202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M112.357202</ArticleId>
            <ArticleId IdType="pmc">PMC3375550</ArticleId>
            <ArticleId IdType="pubmed">22556418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kato H, et al.  Wnt/beta-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival. J Biol Chem. 2011;286:26003–26015. doi: 10.1074/jbc.M111.223164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M111.223164</ArticleId>
            <ArticleId IdType="pmc">PMC3138306</ArticleId>
            <ArticleId IdType="pubmed">21613219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dai C, et al.  Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol. 2009;20:1997–2008. doi: 10.1681/ASN.2009010019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2009010019</ArticleId>
            <ArticleId IdType="pmc">PMC2736766</ArticleId>
            <ArticleId IdType="pubmed">19628668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cain JE, Rosenblum ND. Control of mammalian kidney development by the Hedgehog signaling pathway. Pediatr Nephrol. 2011;26:1365–1371. doi: 10.1007/s00467-010-1704-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00467-010-1704-x</ArticleId>
            <ArticleId IdType="pubmed">21161287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mao J, Kim BM, Rajurkar M, Shivdasani RA, McMahon AP. Hedgehog signaling controls mesenchymal growth in the developing mammalian digestive tract. Development. 2010;137:1721–1729. doi: 10.1242/dev.044586.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.044586</ArticleId>
            <ArticleId IdType="pmc">PMC2860252</ArticleId>
            <ArticleId IdType="pubmed">20430747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao E, Chuang PT. Hedgehog signaling: From basic research to clinical applications. J Formos Med Assoc. 2015;114:569–576. doi: 10.1016/j.jfma.2015.01.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jfma.2015.01.005</ArticleId>
            <ArticleId IdType="pubmed">25701396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abidi A. Hedgehog signaling pathway: a novel target for cancer therapy: vismodegib, a promising therapeutic option in treatment of basal cell carcinomas. Indian J Pharmacol. 2014;46:3–12. doi: 10.4103/0253-7613.124884.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0253-7613.124884</ArticleId>
            <ArticleId IdType="pmc">PMC3912804</ArticleId>
            <ArticleId IdType="pubmed">24550577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katoh Y, Katoh M. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med. 2009;9:873–886.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19860666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie J, et al.  Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature. 1998;391:90–92. doi: 10.1038/34201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/34201</ArticleId>
            <ArticleId IdType="pubmed">9422511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bowers M, et al.  Limb anterior-posterior polarity integrates activator and repressor functions of GLI2 as well as GLI3. Dev Biol. 2012;370:110–124. doi: 10.1016/j.ydbio.2012.07.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ydbio.2012.07.017</ArticleId>
            <ArticleId IdType="pmc">PMC3432687</ArticleId>
            <ArticleId IdType="pubmed">22841643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Attanasio M, et al.  Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis. Nat Genet. 2007;39:1018–1024. doi: 10.1038/ng2072.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng2072</ArticleId>
            <ArticleId IdType="pubmed">17618285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li B, et al.  Increased hedgehog signaling in postnatal kidney results in aberrant activation of nephron developmental programs. Hum Mol Genet. 2011;20:4155–4166. doi: 10.1093/hmg/ddr339.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddr339</ArticleId>
            <ArticleId IdType="pmc">PMC3188992</ArticleId>
            <ArticleId IdType="pubmed">21816948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fabian SL, et al.  Hedgehog-Gli pathway activation during kidney fibrosis. Am J Pathol. 2012;180:1441–1453. doi: 10.1016/j.ajpath.2011.12.039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajpath.2011.12.039</ArticleId>
            <ArticleId IdType="pmc">PMC3349903</ArticleId>
            <ArticleId IdType="pubmed">22342522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou D, et al.  Sonic hedgehog is a novel tubule-derived growth factor for interstitial fibroblasts after kidney injury. J Am Soc Nephrol. 2014;25:2187–2200. doi: 10.1681/ASN.2013080893.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2013080893</ArticleId>
            <ArticleId IdType="pmc">PMC4178435</ArticleId>
            <ArticleId IdType="pubmed">24744439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding H, et al.  Sonic hedgehog signaling mediates epithelial-mesenchymal communication and promotes renal fibrosis. J Am Soc Nephrol. 2012;23:801–813. doi: 10.1681/ASN.2011060614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2011060614</ArticleId>
            <ArticleId IdType="pmc">PMC3338290</ArticleId>
            <ArticleId IdType="pubmed">22302193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kramann R, et al.  Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis. J Clin Invest. 2015 doi: 10.1172/JCI74929.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI74929</ArticleId>
            <ArticleId IdType="pmc">PMC4563736</ArticleId>
            <ArticleId IdType="pubmed">26193634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kramann R, et al.  Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell. 2015;16:51–66. doi: 10.1016/j.stem.2014.11.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stem.2014.11.004</ArticleId>
            <ArticleId IdType="pmc">PMC4289444</ArticleId>
            <ArticleId IdType="pubmed">25465115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schneider J, Arraf AA, Grinstein M, Yelin R, Schultheiss TM. Wnt signaling orients the proximal-distal axis of chick kidney nephrons. Development. 2015;142:2686–2695. doi: 10.1242/dev.123968.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.123968</ArticleId>
            <ArticleId IdType="pubmed">26116665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haegebarth A, Clevers H. Wnt signaling, lgr5, and stem cells in the intestine and skin. Am J Pathol. 2009;174:715–721. doi: 10.2353/ajpath.2009.080758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2353/ajpath.2009.080758</ArticleId>
            <ArticleId IdType="pmc">PMC2665733</ArticleId>
            <ArticleId IdType="pubmed">19197002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krausova M, Korinek V. Wnt signaling in adult intestinal stem cells and cancer. Cell Signal. 2014;26:570–579. doi: 10.1016/j.cellsig.2013.11.032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellsig.2013.11.032</ArticleId>
            <ArticleId IdType="pubmed">24308963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vooijs M, Liu Z, Kopan R. Notch: architect, landscaper, and guardian of the intestine. Gastroenterology. 2011;141:448–459. doi: 10.1053/j.gastro.2011.06.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2011.06.003</ArticleId>
            <ArticleId IdType="pmc">PMC4050496</ArticleId>
            <ArticleId IdType="pubmed">21689653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van der Flier LG, Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol. 2009;71:241–260. doi: 10.1146/annurev.physiol.010908.163145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.physiol.010908.163145</ArticleId>
            <ArticleId IdType="pubmed">18808327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao Z, et al.  Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis. Nature medicine. 2016;22:154–162. doi: 10.1038/nm.4035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.4035</ArticleId>
            <ArticleId IdType="pmc">PMC4872630</ArticleId>
            <ArticleId IdType="pubmed">26779814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005;434:843–850. doi: 10.1038/nature03319.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature03319</ArticleId>
            <ArticleId IdType="pubmed">15829953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kramann R, et al.  Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis. The Journal of clinical investigation. 2015;125:2935–2951. doi: 10.1172/JCI74929.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI74929</ArticleId>
            <ArticleId IdType="pmc">PMC4563736</ArticleId>
            <ArticleId IdType="pubmed">26193634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobayashi T, et al.  Expression and function of the Delta-1/Notch-2/Hes-1 pathway during experimental acute kidney injury. Kidney Int. 2008;73:1240–1250. doi: 10.1038/ki.2008.74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2008.74</ArticleId>
            <ArticleId IdType="pubmed">18418349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta S, et al.  Effect of Notch activation on the regenerative response to acute renal failure. Am J Physiol Renal Physiol. 2010;298:F209–215. doi: 10.1152/ajprenal.00451.2009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.00451.2009</ArticleId>
            <ArticleId IdType="pubmed">19828677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walsh DW, et al.  Co-regulation of Gremlin and Notch signalling in diabetic nephropathy. Biochimica et biophysica acta. 2008;1782:10–21. doi: 10.1016/j.bbadis.2007.09.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbadis.2007.09.005</ArticleId>
            <ArticleId IdType="pubmed">17980714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simic D, et al.  Determination of relative Notch1 and gamma-secretase-related gene expression in puromycin-treated microdissected rat kidneys. Gene Expr. 2013;16:39–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24397211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Surendran K, McCaul SP, Simon TC. A role for Wnt-4 in renal fibrosis. Am J Physiol Renal Physiol. 2002;282:F431–441. doi: 10.1152/ajprenal.0009.2001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.0009.2001</ArticleId>
            <ArticleId IdType="pubmed">11832423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuma A, et al.  Role of WNT10A-expressing kidney fibroblasts in acute interstitial nephritis. PLoS One. 2014;9:e103240. doi: 10.1371/journal.pone.0103240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0103240</ArticleId>
            <ArticleId IdType="pmc">PMC4108433</ArticleId>
            <ArticleId IdType="pubmed">25054240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim MK, et al.  The differential expression of TGF-beta1, ILK and wnt signaling inducing epithelial to mesenchymal transition in human renal fibrogenesis: an immunohistochemical study. Int J Clin Exp Pathol. 2013;6:1747–1758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3759481</ArticleId>
            <ArticleId IdType="pubmed">24040439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang D, Dai C, Li Y, Liu Y. Canonical Wnt/beta-catenin signaling mediates transforming growth factor-beta1-driven podocyte injury and proteinuria. Kidney Int. 2011;80:1159–1169. doi: 10.1038/ki.2011.255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2011.255</ArticleId>
            <ArticleId IdType="pmc">PMC4300105</ArticleId>
            <ArticleId IdType="pubmed">21832980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang L, et al.  Calmodulin-dependent protein kinase II/cAMP response element-binding protein/Wnt/beta-catenin signaling cascade regulates angiotensin II-induced podocyte injury and albuminuria. J Biol Chem. 2013;288:23368–23379. doi: 10.1074/jbc.M113.460394.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M113.460394</ArticleId>
            <ArticleId IdType="pmc">PMC3743506</ArticleId>
            <ArticleId IdType="pubmed">23803607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren S, et al.  LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1. Proc Natl Acad Sci U S A. 2013;110:1440–1445. doi: 10.1073/pnas.1211179110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1211179110</ArticleId>
            <ArticleId IdType="pmc">PMC3557093</ArticleId>
            <ArticleId IdType="pubmed">23302695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hao S, et al.  Targeted inhibition of beta-catenin/CBP signaling ameliorates renal interstitial fibrosis. J Am Soc Nephrol. 2011;22:1642–1653. doi: 10.1681/ASN.2010101079.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2010101079</ArticleId>
            <ArticleId IdType="pmc">PMC3171936</ArticleId>
            <ArticleId IdType="pubmed">21816937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He W, Kang YS, Dai C, Liu Y. Blockade of Wnt/beta-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J Am Soc Nephrol. 2011;22:90–103. doi: 10.1681/ASN.2009121236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2009121236</ArticleId>
            <ArticleId IdType="pmc">PMC3014038</ArticleId>
            <ArticleId IdType="pubmed">21030600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Surendran K, Schiavi S, Hruska KA. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol. 2005;16:2373–2384. doi: 10.1681/ASN.2004110949.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2004110949</ArticleId>
            <ArticleId IdType="pubmed">15944336</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">27140856</PMID>
      <DateCompleted>
        <Year>2017</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1759-507X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>12</Volume>
            <Issue>7</Issue>
            <PubDate>
              <Year>2016</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nature reviews. Nephrology</Title>
          <ISOAbbreviation>Nat Rev Nephrol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog.</ArticleTitle>
        <Pagination>
          <StartPage>426</StartPage>
          <EndPage>439</EndPage>
          <MedlinePgn>426-39</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/nrneph.2016.54</ELocationID>
        <Abstract>
          <AbstractText>Kidney fibrosis is a common histological manifestation of functional decline in the kidney. Fibrosis is a reactive process that develops in response to excessive epithelial injury and inflammation, leading to myofibroblast activation and an accumulation of extracellular matrix. Here, we describe how three key developmental signalling pathways - Notch, Wnt and Hedgehog (Hh) - are reactivated in response to kidney injury and contribute to the fibrotic response. Although transient activation of these pathways is needed for repair of injured tissue, their sustained activation is thought to promote fibrosis. Excessive Wnt and Notch expression prohibit epithelial differentiation, whereas increased Wnt and Hh expression induce fibroblast proliferation and myofibroblastic transdifferentiation. Notch, Wnt and Hh are fundamentally different signalling pathways, but their choreographed activation seems to be just as important for fibrosis as it is for embryonic kidney development. Decreasing the activity of Notch, Wnt or Hh signalling could potentially provide a new therapeutic strategy to ameliorate the development of fibrosis in chronic kidney disease.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Edeling</LastName>
            <ForeName>Maria</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Renal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 415 Curie Boulevard, 415 Clinical Research Building, Philadelphia, Pennsylvania 19104, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Nephrology, Internal Medicine D, University Hospital Albert-Schweitzer-Straße 33, Münster 48149, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ragi</LastName>
            <ForeName>Grace</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Renal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 415 Curie Boulevard, 415 Clinical Research Building, Philadelphia, Pennsylvania 19104, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Shizheng</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Renal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 415 Curie Boulevard, 415 Clinical Research Building, Philadelphia, Pennsylvania 19104, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pavenstädt</LastName>
            <ForeName>Hermann</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Nephrology, Internal Medicine D, University Hospital Albert-Schweitzer-Straße 33, Münster 48149, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Susztak</LastName>
            <ForeName>Katalin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Renal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 415 Curie Boulevard, 415 Clinical Research Building, Philadelphia, Pennsylvania 19104, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>DP3 DK108220</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK076077</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK087635</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK105821</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2016</Year>
          <Month>05</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Nat Rev Nephrol</MedlineTA>
        <NlmUniqueID>101500081</NlmUniqueID>
        <ISSNLinking>1759-5061</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053823">Hedgehog Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051880">Receptors, Notch</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053823" MajorTopicYN="N">Hedgehog Proteins</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050199" MajorTopicYN="N">Podocytes</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051880" MajorTopicYN="N">Receptors, Notch</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060449" MajorTopicYN="N">Wnt Signaling Pathway</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement><b>Competing interests</b>. The Susztaklab received research support from Boehringer Ingelheim, Biogen and Lilly.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2017</Year>
          <Month>5</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">27140856</ArticleId>
        <ArticleId IdType="mid">NIHMS876485</ArticleId>
        <ArticleId IdType="pmc">PMC5529143</ArticleId>
        <ArticleId IdType="doi">10.1038/nrneph.2016.54</ArticleId>
        <ArticleId IdType="pii">nrneph.2016.54</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Jha V. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260–272. doi: 10.1016/S0140-6736(13)60687-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(13)60687-X</ArticleId>
            <ArticleId IdType="pubmed">23727169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 2006;69:213–217. doi: 10.1038/sj.ki.5000054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.ki.5000054</ArticleId>
            <ArticleId IdType="pubmed">16408108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tonelli M, et al.  Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17:2034–2047. doi: 10.1681/ASN.2005101085.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2005101085</ArticleId>
            <ArticleId IdType="pubmed">16738019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reidy K, Kang HM, Hostetter T, Susztak K. Molecular mechanisms of diabetic kidney disease. J Clin Invest. 2014;124:2333–2340. doi: 10.1172/JCI72271.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI72271</ArticleId>
            <ArticleId IdType="pmc">PMC4089448</ArticleId>
            <ArticleId IdType="pubmed">24892707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duffield JS. Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest. 2014;124:2299–2306. doi: 10.1172/JCI72267.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI72267</ArticleId>
            <ArticleId IdType="pmc">PMC4038570</ArticleId>
            <ArticleId IdType="pubmed">24892703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol. 2011;7:684–696. doi: 10.1038/nrneph.2011.149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrneph.2011.149</ArticleId>
            <ArticleId IdType="pmc">PMC4520424</ArticleId>
            <ArticleId IdType="pubmed">22009250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaissling B, Lehir M, Kriz W. Renal epithelial injury and fibrosis. Biochim Biophys Acta. 2013;1832:931–939. doi: 10.1016/j.bbadis.2013.02.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbadis.2013.02.010</ArticleId>
            <ArticleId IdType="pubmed">23466594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grgic I, Duffield JS, Humphreys BD. The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol. 2012;27:183–193. doi: 10.1007/s00467-011-1772-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00467-011-1772-6</ArticleId>
            <ArticleId IdType="pmc">PMC3116994</ArticleId>
            <ArticleId IdType="pubmed">21311912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Humphreys BD, et al.  Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol. 2010;176:85–97. doi: 10.2353/ajpath.2010.090517.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2353/ajpath.2010.090517</ArticleId>
            <ArticleId IdType="pmc">PMC2797872</ArticleId>
            <ArticleId IdType="pubmed">20008127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woroniecka KI, et al.  Transcriptome analysis of human diabetic kidney disease. Diabetes. 2011;60:2354–2369. doi: 10.2337/db10-1181.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db10-1181</ArticleId>
            <ArticleId IdType="pmc">PMC3161334</ArticleId>
            <ArticleId IdType="pubmed">21752957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Susztak K, Raff AC, Schiffer M, Bottinger EP. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes. 2006;55:225–233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16380497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huber TB, et al.  Emerging role of autophagy in kidney function, diseases and aging. Autophagy. 2012;8:1009–1031. doi: 10.4161/auto.19821.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/auto.19821</ArticleId>
            <ArticleId IdType="pmc">PMC3429540</ArticleId>
            <ArticleId IdType="pubmed">22692002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lieberthal W, Levine JS. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am J Physiol. 1996;271:F477–488.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8853409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ueda N, Kaushal GP, Shah SV. Recent advances in understanding mechanisms of renal tubular injury. Adv Ren Replace Ther. 1997;4:17–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9113237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lieberthal W, Koh JS, Levine JS. Necrosis and apoptosis in acute renal failure. Semin Nephrol. 1998;18:505–518.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9754603</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petermann A, Floege J. Podocyte damage resulting in podocyturia: a potential diagnostic marker to assess glomerular disease activity. Nephron Clin Pract. 2007;106:c61–66. doi: 10.1159/000101799.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000101799</ArticleId>
            <ArticleId IdType="pubmed">17570931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest. 2011;121:4210–4221. doi: 10.1172/JCI45161.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI45161</ArticleId>
            <ArticleId IdType="pmc">PMC3204829</ArticleId>
            <ArticleId IdType="pubmed">22045571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hakroush S, et al.  Extensive podocyte loss triggers a rapid parietal epithelial cell response. J Am Soc Nephrol. 2014;25:927–938. doi: 10.1681/ASN.2013070687.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2013070687</ArticleId>
            <ArticleId IdType="pmc">PMC4005306</ArticleId>
            <ArticleId IdType="pubmed">24335975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eng DG, et al.  Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis. Kidney Int. 2015;88:999–1012. doi: 10.1038/ki.2015.152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2015.152</ArticleId>
            <ArticleId IdType="pmc">PMC4654724</ArticleId>
            <ArticleId IdType="pubmed">25993321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wharram BL, et al.  Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol. 2005;16:2941–2952. doi: 10.1681/ASN.2005010055.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2005010055</ArticleId>
            <ArticleId IdType="pubmed">16107576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rutkowski JM, et al.  Adiponectin promotes functional recovery after podocyte ablation. J Am Soc Nephrol. 2013;24:268–282. doi: 10.1681/ASN.2012040414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2012040414</ArticleId>
            <ArticleId IdType="pmc">PMC3559480</ArticleId>
            <ArticleId IdType="pubmed">23334396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inoki K, et al.  mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest. 2011;121:2181–2196. doi: 10.1172/JCI44771.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI44771</ArticleId>
            <ArticleId IdType="pmc">PMC3104745</ArticleId>
            <ArticleId IdType="pubmed">21606597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Godel M, et al.  Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest. 2011;121:2197–2209. doi: 10.1172/JCI44774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI44774</ArticleId>
            <ArticleId IdType="pmc">PMC3104746</ArticleId>
            <ArticleId IdType="pubmed">21606591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wiggins JE, et al.  Podocyte hypertrophy, “adaptation,” and “decompensation” associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol. 2005;16:2953–2966. doi: 10.1681/ASN.2005050488.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2005050488</ArticleId>
            <ArticleId IdType="pubmed">16120818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pagtalunan ME, et al.  Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest. 1997;99:342–348. doi: 10.1172/JCI119163.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI119163</ArticleId>
            <ArticleId IdType="pmc">PMC507802</ArticleId>
            <ArticleId IdType="pubmed">9006003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes. 2005;54:1626–1634.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15919782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dimke H, et al.  Tubulovascular Cross-Talk by Vascular Endothelial Growth Factor A Maintains Peritubular Microvasculature in Kidney. J Am Soc Nephrol. 2014 doi: 10.1681/ASN.2014010060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2014010060</ArticleId>
            <ArticleId IdType="pmc">PMC4413754</ArticleId>
            <ArticleId IdType="pubmed">25385849</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol. 2005;15:599–607. doi: 10.1016/j.tcb.2005.09.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tcb.2005.09.002</ArticleId>
            <ArticleId IdType="pubmed">16202600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gu L, et al.  Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy. AIDS. 2013;27:1091–1098. doi: 10.1097/QAD.0b013e32835f1ea1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/QAD.0b013e32835f1ea1</ArticleId>
            <ArticleId IdType="pmc">PMC3918880</ArticleId>
            <ArticleId IdType="pubmed">23343908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dai Y, et al.  Podocyte-specific deletion of signal transducer and activator of transcription 3 attenuates nephrotoxic serum-induced glomerulonephritis. Kidney Int. 2013;84:950–961. doi: 10.1038/ki.2013.197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2013.197</ArticleId>
            <ArticleId IdType="pmc">PMC3797218</ArticleId>
            <ArticleId IdType="pubmed">23842188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 2001;107:7–11. doi: 10.1172/JCI11830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI11830</ArticleId>
            <ArticleId IdType="pmc">PMC198552</ArticleId>
            <ArticleId IdType="pubmed">11134171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng XM, Nikolic-Paterson DJ, Lan HY. Inflammatory processes in renal fibrosis. Nat Rev Nephrol. 2014;10:493–503. doi: 10.1038/nrneph.2014.114.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrneph.2014.114</ArticleId>
            <ArticleId IdType="pubmed">24981817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar D, Singla SK, Puri V, Puri S. The restrained expression of NF-kB in renal tissue ameliorates folic acid induced acute kidney injury in mice. PLoS One. 2015;10:e115947. doi: 10.1371/journal.pone.0115947.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0115947</ArticleId>
            <ArticleId IdType="pmc">PMC4283964</ArticleId>
            <ArticleId IdType="pubmed">25559736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okabe C, et al.  NF-kappaB activation mediates crystal translocation and interstitial inflammation in adenine overload nephropathy. Am J Physiol Renal Physiol. 2013;305:F155–163. doi: 10.1152/ajprenal.00491.2012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.00491.2012</ArticleId>
            <ArticleId IdType="pubmed">23657853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yukawa K, et al.  STAT6 deficiency inhibits tubulointerstitial fibrosis in obstructive nephropathy. Int J Mol Med. 2005;15:225–230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15647835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedman SL, Sheppard D, Duffield JS, Violette S. Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med. 2013;5:167sr161. doi: 10.1126/scitranslmed.3004700.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scitranslmed.3004700</ArticleId>
            <ArticleId IdType="pubmed">23303606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meran S, Steadman R. Fibroblasts and myofibroblasts in renal fibrosis. Int J Exp Pathol. 2011;92:158–167. doi: 10.1111/j.1365-2613.2011.00764.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2613.2011.00764.x</ArticleId>
            <ArticleId IdType="pmc">PMC3101489</ArticleId>
            <ArticleId IdType="pubmed">21355940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu B, Phan SH. Myofibroblasts. Curr Opin Rheumatol. 2013;25:71–77. doi: 10.1097/BOR.0b013e32835b1352.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/BOR.0b013e32835b1352</ArticleId>
            <ArticleId IdType="pmc">PMC4007118</ArticleId>
            <ArticleId IdType="pubmed">23114586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kendall RT, Feghali-Bostwick CA. Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol. 2014;5:123. doi: 10.3389/fphar.2014.00123.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2014.00123</ArticleId>
            <ArticleId IdType="pmc">PMC4034148</ArticleId>
            <ArticleId IdType="pubmed">24904424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klingberg F, Hinz B, White ES. The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol. 2013;229:298–309. doi: 10.1002/path.4104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/path.4104</ArticleId>
            <ArticleId IdType="pmc">PMC4005341</ArticleId>
            <ArticleId IdType="pubmed">22996908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wight TN, Potter-Perigo S. The extracellular matrix: an active or passive player in fibrosis. Am J Physiol Gastrointest Liver Physiol. 2011;301:G950–955. doi: 10.1152/ajpgi.00132.2011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpgi.00132.2011</ArticleId>
            <ArticleId IdType="pmc">PMC3233785</ArticleId>
            <ArticleId IdType="pubmed">21512158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olsen AL, et al.  Hepatic stellate cells require a stiff environment for myofibroblastic differentiation. Am J Physiol Gastrointest Liver Physiol. 2011;301:G110–118. doi: 10.1152/ajpgi.00412.2010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpgi.00412.2010</ArticleId>
            <ArticleId IdType="pmc">PMC3129929</ArticleId>
            <ArticleId IdType="pubmed">21527725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Urban ML, Manenti L, Vaglio A. Fibrosis–A Common Pathway to Organ Injury and Failure. N Engl J Med. 2015;373:95–96. doi: 10.1056/NEJMc1504848#SA2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc1504848#SA2</ArticleId>
            <ArticleId IdType="pubmed">26132961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest. 2007;117:524–529. doi: 10.1172/JCI31487.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI31487</ArticleId>
            <ArticleId IdType="pmc">PMC1804380</ArticleId>
            <ArticleId IdType="pubmed">17332879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lavoz C, et al.  Angiotensin II contributes to renal fibrosis independently of Notch pathway activation. PLoS One. 2012;7:e40490. doi: 10.1371/journal.pone.0040490.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0040490</ArticleId>
            <ArticleId IdType="pmc">PMC3392235</ArticleId>
            <ArticleId IdType="pubmed">22792351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boor P, Floege J. Chronic kidney disease growth factors in renal fibrosis. Clin Exp Pharmacol Physiol. 2011;38:441–450. doi: 10.1111/j.1440-1681.2011.05487.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1440-1681.2011.05487.x</ArticleId>
            <ArticleId IdType="pubmed">21276040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chuang PY, Menon MC, He JC. Molecular targets for treatment of kidney fibrosis. J Mol Med (Berl) 2013;91:549–559. doi: 10.1007/s00109-012-0983-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00109-012-0983-z</ArticleId>
            <ArticleId IdType="pmc">PMC3594378</ArticleId>
            <ArticleId IdType="pubmed">23179685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shull MM, et al.  Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992;359:693–699. doi: 10.1038/359693a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/359693a0</ArticleId>
            <ArticleId IdType="pmc">PMC3889166</ArticleId>
            <ArticleId IdType="pubmed">1436033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kulkarni AB, et al.  Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A. 1993;90:770–774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC45747</ArticleId>
            <ArticleId IdType="pubmed">8421714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai EC. Notch signaling: control of cell communication and cell fate. Development. 2004;131:965–973. doi: 10.1242/dev.01074.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.01074</ArticleId>
            <ArticleId IdType="pubmed">14973298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ilagan MX, Lim S, Fulbright M, Piwnica-Worms D, Kopan R. Real-time imaging of notch activation with a luciferase complementation-based reporter. Sci Signal. 2011;4:rs7. doi: 10.1126/scisignal.2001656.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scisignal.2001656</ArticleId>
            <ArticleId IdType="pmc">PMC3387985</ArticleId>
            <ArticleId IdType="pubmed">21775282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137:216–233. doi: 10.1016/j.cell.2009.03.045.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2009.03.045</ArticleId>
            <ArticleId IdType="pmc">PMC2827930</ArticleId>
            <ArticleId IdType="pubmed">19379690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sirin Y, Susztak K. Notch in the kidney: development and disease. J Pathol. 2012;226:394–403. doi: 10.1002/path.2967.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/path.2967</ArticleId>
            <ArticleId IdType="pmc">PMC3677191</ArticleId>
            <ArticleId IdType="pubmed">21952830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Penton AL, Leonard LD, Spinner NB. Notch signaling in human development and disease. Semin Cell Dev Biol. 2012;23:450–457. doi: 10.1016/j.semcdb.2012.01.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semcdb.2012.01.010</ArticleId>
            <ArticleId IdType="pmc">PMC3638987</ArticleId>
            <ArticleId IdType="pubmed">22306179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng HT, et al.  Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development. 2007;134:801–811. doi: 10.1242/dev.02773.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.02773</ArticleId>
            <ArticleId IdType="pmc">PMC2613851</ArticleId>
            <ArticleId IdType="pubmed">17229764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujimura S, Jiang Q, Kobayashi C, Nishinakamura R. Notch2 activation in the embryonic kidney depletes nephron progenitors. J Am Soc Nephrol. 2010;21:803–810. doi: 10.1681/ASN.2009040353.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2009040353</ArticleId>
            <ArticleId IdType="pmc">PMC2865736</ArticleId>
            <ArticleId IdType="pubmed">20299358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Djudjaj S, et al.  Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury. J Pathol. 2012;228:286–299. doi: 10.1002/path.4076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/path.4076</ArticleId>
            <ArticleId IdType="pubmed">22806125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma S, Sirin Y, Susztak K. The story of Notch and chronic kidney disease. Curr Opin Nephrol Hypertens. 2011;20:56–61. doi: 10.1097/MNH.0b013e3283414c88.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MNH.0b013e3283414c88</ArticleId>
            <ArticleId IdType="pmc">PMC3164509</ArticleId>
            <ArticleId IdType="pubmed">21088575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carulli AJ, et al.  Notch receptor regulation of intestinal stem cell homeostasis and crypt regeneration. Dev Biol. 2015;402:98–108. doi: 10.1016/j.ydbio.2015.03.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ydbio.2015.03.012</ArticleId>
            <ArticleId IdType="pmc">PMC4433599</ArticleId>
            <ArticleId IdType="pubmed">25835502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barker N, et al.  Lgr5(+ve) stem/progenitor cells contribute to nephron formation during kidney development. Cell Rep. 2012;2:540–552. doi: 10.1016/j.celrep.2012.08.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2012.08.018</ArticleId>
            <ArticleId IdType="pubmed">22999937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pleniceanu O, Harari-Steinberg O, Dekel B. Concise review: Kidney stem/progenitor cells: differentiate, sort out, or reprogram. Stem Cells. 2010;28:1649–1660. doi: 10.1002/stem.486.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/stem.486</ArticleId>
            <ArticleId IdType="pmc">PMC2996087</ArticleId>
            <ArticleId IdType="pubmed">20652959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar S, et al.  Sox9 Activation Highlights a Cellular Pathway of Renal Repair in the Acutely Injured Mammalian Kidney. Cell Rep. 2015;12:1325–1338. doi: 10.1016/j.celrep.2015.07.034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2015.07.034</ArticleId>
            <ArticleId IdType="pubmed">26279573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reginensi A, et al.  SOX9 controls epithelial branching by activating RET effector genes during kidney development. Hum Mol Genet. 2011;20:1143–1153. doi: 10.1093/hmg/ddq558.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddq558</ArticleId>
            <ArticleId IdType="pmc">PMC3809456</ArticleId>
            <ArticleId IdType="pubmed">21212101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang HM, et al.  Sox9-Positive Progenitor Cells Play a Key Role in Renal Tubule Epithelial Regeneration in Mice. Cell Rep. 2016;14:861–871. doi: 10.1016/j.celrep.2015.12.071.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2015.12.071</ArticleId>
            <ArticleId IdType="pmc">PMC4854207</ArticleId>
            <ArticleId IdType="pubmed">26776520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomez RA, Belyea B, Medrano S, Pentz ES, Sequeira-Lopez ML. Fate and plasticity of renin precursors in development and disease. Pediatr Nephrol. 2014;29:721–726. doi: 10.1007/s00467-013-2688-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00467-013-2688-0</ArticleId>
            <ArticleId IdType="pmc">PMC3999616</ArticleId>
            <ArticleId IdType="pubmed">24337407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bussolati B, et al.  Isolation of renal progenitor cells from adult human kidney. Am J Pathol. 2005;166(10):545–555. 62276–6. doi: 10.1016/S0002-9440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0002-9440</ArticleId>
            <ArticleId IdType="pmc">PMC1602314</ArticleId>
            <ArticleId IdType="pubmed">15681837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J, Chen JK, Conway EM, Harris RC. Survivin mediates renal proximal tubule recovery from AKI. J Am Soc Nephrol. 2013;24:2023–2033. doi: 10.1681/ASN.2013010076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2013010076</ArticleId>
            <ArticleId IdType="pmc">PMC3839548</ArticleId>
            <ArticleId IdType="pubmed">23949800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang R, Zhou Q, Veeraragoo P, Yu H, Xiao Z. Notch2/Hes-1 pathway plays an important role in renal ischemia and reperfusion injury-associated inflammation and apoptosis and the gamma-secretase inhibitor DAPT has a nephroprotective effect. Ren Fail. 2011;33:207–216. doi: 10.3109/0886022X.2011.553979.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/0886022X.2011.553979</ArticleId>
            <ArticleId IdType="pubmed">21332343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sorensen-Zender I, et al.  Renal tubular Notch signaling triggers a prosenescent state after acute kidney injury. Am J Physiol Renal Physiol. 2014;306:F907–915. doi: 10.1152/ajprenal.00030.2014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.00030.2014</ArticleId>
            <ArticleId IdType="pubmed">24573392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murea M, et al.  Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. Kidney Int. 2010;78:514–522. doi: 10.1038/ki.2010.172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2010.172</ArticleId>
            <ArticleId IdType="pmc">PMC3164583</ArticleId>
            <ArticleId IdType="pubmed">20531454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bielesz B, et al.  Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest. 2010;120:4040–4054. doi: 10.1172/JCI43025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI43025</ArticleId>
            <ArticleId IdType="pmc">PMC2964979</ArticleId>
            <ArticleId IdType="pubmed">20978353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, Li Y, Kong D, Sarkar FH. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Curr Drug Targets. 2010;11:745–751.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3084452</ArticleId>
            <ArticleId IdType="pubmed">20041844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saad S, Stanners SR, Yong R, Tang O, Pollock CA. Notch mediated epithelial to mesenchymal transformation is associated with increased expression of the Snail transcription factor. Int J Biochem Cell Biol. 2010;42:1115–1122. doi: 10.1016/j.biocel.2010.03.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biocel.2010.03.016</ArticleId>
            <ArticleId IdType="pubmed">20348013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grande MT, et al.  Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat Med. 2015;21:989–997. doi: 10.1038/nm.3901.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.3901</ArticleId>
            <ArticleId IdType="pubmed">26236989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lovisa S, et al.  Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat Med. 2015;21:998–1009. doi: 10.1038/nm.3902.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.3902</ArticleId>
            <ArticleId IdType="pmc">PMC4587560</ArticleId>
            <ArticleId IdType="pubmed">26236991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lasagni L, et al.  Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. Stem Cells. 2010;28:1674–1685. doi: 10.1002/stem.492.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/stem.492</ArticleId>
            <ArticleId IdType="pmc">PMC2996085</ArticleId>
            <ArticleId IdType="pubmed">20680961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen L, Al-Awqati Q. Segmental expression of Notch and Hairy genes in nephrogenesis. Am J Physiol Renal Physiol. 2005;288:F939–952. doi: 10.1152/ajprenal.00369.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.00369.2004</ArticleId>
            <ArticleId IdType="pubmed">15821257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barak H, Surendran K, Boyle SC. The role of Notch signaling in kidney development and disease. Adv Exp Med Biol. 2012;727:99–113. doi: 10.1007/978-1-4614-0899-4_8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-4614-0899-4_8</ArticleId>
            <ArticleId IdType="pubmed">22399342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bielefeld KA, Amini-Nik S, Alman BA. Cutaneous wound healing: recruiting developmental pathways for regeneration. Cell Mol Life Sci. 2013;70:2059–2081. doi: 10.1007/s00018-012-1152-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-012-1152-9</ArticleId>
            <ArticleId IdType="pmc">PMC3663196</ArticleId>
            <ArticleId IdType="pubmed">23052205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao Z, et al.  The Notch gamma-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-beta/Smad2/3 signaling pathway activation. Int J Biochem Cell Biol. 2014;55:65–71. doi: 10.1016/j.biocel.2014.08.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biocel.2014.08.009</ArticleId>
            <ArticleId IdType="pubmed">25150830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takebe N, Harris PJ, Warren RQ, Ivy SP. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol. 2011;8:97–106. doi: 10.1038/nrclinonc.2010.196.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrclinonc.2010.196</ArticleId>
            <ArticleId IdType="pubmed">21151206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayward P, Kalmar T, Arias AM. Wnt/Notch signalling and information processing during development. Development. 2008;135:411–424. doi: 10.1242/dev.000505.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.000505</ArticleId>
            <ArticleId IdType="pubmed">18192283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niranjan T, et al.  The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med. 2008;14:290–298. doi: 10.1038/nm1731.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm1731</ArticleId>
            <ArticleId IdType="pubmed">18311147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niranjan T, Murea M, Susztak K. The pathogenic role of Notch activation in podocytes. Nephron Exp Nephrol. 2009;111:e73–79. doi: 10.1159/000209207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000209207</ArticleId>
            <ArticleId IdType="pmc">PMC2851161</ArticleId>
            <ArticleId IdType="pubmed">19293596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin CL, et al.  Modulation of notch-1 signaling alleviates vascular endothelial growth factor-mediated diabetic nephropathy. Diabetes. 2010;59:1915–1925. doi: 10.2337/db09-0663.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db09-0663</ArticleId>
            <ArticleId IdType="pmc">PMC2911050</ArticleId>
            <ArticleId IdType="pubmed">20522599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanaka E, et al.  Notch2 activation ameliorates nephrosis. Nat Commun. 2014;5:3296. doi: 10.1038/ncomms4296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms4296</ArticleId>
            <ArticleId IdType="pubmed">24526233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arking DE, et al.  Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization. Nat Genet. 2014;46:826–836. doi: 10.1038/ng.3014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng.3014</ArticleId>
            <ArticleId IdType="pmc">PMC4124521</ArticleId>
            <ArticleId IdType="pubmed">24952745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sweetwyne MT, et al.  Notch1 and Notch2 in Podocytes Play Differential Roles During Diabetic Nephropathy Development. Diabetes. 2015;64:4099–4111. doi: 10.2337/db15-0260.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db15-0260</ArticleId>
            <ArticleId IdType="pmc">PMC4657584</ArticleId>
            <ArticleId IdType="pubmed">26293507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El Machhour F, Keuylian Z, Kavvadas P, Dussaule JC, Chatziantoniou C. Activation of Notch3 in Glomeruli Promotes the Development of Rapidly Progressive Renal Disease. J Am Soc Nephrol. 2015;26:1561–1575. doi: 10.1681/ASN.2013090968.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2013090968</ArticleId>
            <ArticleId IdType="pmc">PMC4483574</ArticleId>
            <ArticleId IdType="pubmed">25421557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nusse R, Varmus H. Three decades of Wnts: a personal perspective on how a scientific field developed. EMBO J. 2012;31:2670–2684. doi: 10.1038/emboj.2012.146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/emboj.2012.146</ArticleId>
            <ArticleId IdType="pmc">PMC3380217</ArticleId>
            <ArticleId IdType="pubmed">22617420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sokol SY. Spatial and temporal aspects of Wnt signaling and planar cell polarity during vertebrate embryonic development. Semin Cell Dev Biol. 2015;42:78–85. doi: 10.1016/j.semcdb.2015.05.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semcdb.2015.05.002</ArticleId>
            <ArticleId IdType="pmc">PMC4562884</ArticleId>
            <ArticleId IdType="pubmed">25986055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kahn M. Can we safely target the WNT pathway. Nat Rev Drug Discov. 2014;13:513–532. doi: 10.1038/nrd4233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrd4233</ArticleId>
            <ArticleId IdType="pmc">PMC4426976</ArticleId>
            <ArticleId IdType="pubmed">24981364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holland JD, Klaus A, Garratt AN, Birchmeier W. Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol. 2013;25:254–264. doi: 10.1016/j.ceb.2013.01.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ceb.2013.01.004</ArticleId>
            <ArticleId IdType="pubmed">23347562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo Y, Xiao L, Sun L, Liu F. Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. Physiol Res. 2012;61:337–346.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22670697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He X, Semenov M, Tamai K, Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development. 2004;131:1663–1677. doi: 10.1242/dev.01117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.01117</ArticleId>
            <ArticleId IdType="pubmed">15084453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moon RT, Kohn AD, De Ferrari GV, Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet. 2004;5:691–701. doi: 10.1038/nrg1427.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrg1427</ArticleId>
            <ArticleId IdType="pubmed">15372092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boyle SC, Kim M, Valerius MT, McMahon AP, Kopan R. Notch pathway activation can replace the requirement for Wnt4 and Wnt9b in mesenchymal-to-epithelial transition of nephron stem cells. Development. 2011;138:4245–4254. doi: 10.1242/dev.070433.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.070433</ArticleId>
            <ArticleId IdType="pmc">PMC3171224</ArticleId>
            <ArticleId IdType="pubmed">21852398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosenberg SL, Chen S, McLaughlin N, El-Dahr SS. Regulation of kidney development by histone deacetylases. Pediatr Nephrol. 2011;26:1445–1452. doi: 10.1007/s00467-011-1796-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00467-011-1796-y</ArticleId>
            <ArticleId IdType="pmc">PMC3199300</ArticleId>
            <ArticleId IdType="pubmed">21336812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawakami T, Ren S, Duffield JS. Wnt signalling in kidney diseases: dual roles in renal injury and repair. J Pathol. 2013;229:221–231. doi: 10.1002/path.4121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/path.4121</ArticleId>
            <ArticleId IdType="pubmed">23097132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliver JA, Maarouf O, Cheema FH, Martens TP, Al-Awqati Q. The renal papilla is a niche for adult kidney stem cells. J Clin Invest. 2004;114:795–804. doi: 10.1172/JCI20921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI20921</ArticleId>
            <ArticleId IdType="pmc">PMC516259</ArticleId>
            <ArticleId IdType="pubmed">15372103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rinkevich Y, et al.  In vivo clonal analysis reveals lineage-restricted progenitor characteristics in mammalian kidney development, maintenance, and regeneration. Cell Rep. 2014;7:1270–1283. doi: 10.1016/j.celrep.2014.04.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2014.04.018</ArticleId>
            <ArticleId IdType="pmc">PMC4425291</ArticleId>
            <ArticleId IdType="pubmed">24835991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin SL, et al.  Macrophage Wnt7b is critical for kidney repair and regeneration. Proc Natl Acad Sci U S A. 2010;107:4194–4199. doi: 10.1073/pnas.0912228107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0912228107</ArticleId>
            <ArticleId IdType="pmc">PMC2840080</ArticleId>
            <ArticleId IdType="pubmed">20160075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao L, et al.  Sustained Activation of Wnt/beta-Catenin Signaling Drives AKI to CKD Progression. J Am Soc Nephrol. 2015 doi: 10.1681/ASN.2015040449.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2015040449</ArticleId>
            <ArticleId IdType="pmc">PMC4884114</ArticleId>
            <ArticleId IdType="pubmed">26453613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terada Y, et al.  Expression and function of the developmental gene Wnt-4 during experimental acute renal failure in rats. J Am Soc Nephrol. 2003;14:1223–1233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12707392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou D, et al.  Tubule-specific ablation of endogenous beta-catenin aggravates acute kidney injury in mice. Kidney Int. 2012;82:537–547. doi: 10.1038/ki.2012.173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2012.173</ArticleId>
            <ArticleId IdType="pmc">PMC3425732</ArticleId>
            <ArticleId IdType="pubmed">22622501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He W, et al.  Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol. 2009;20:765–776. doi: 10.1681/ASN.2008060566.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2008060566</ArticleId>
            <ArticleId IdType="pmc">PMC2663839</ArticleId>
            <ArticleId IdType="pubmed">19297557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou D, Tan RJ, Zhou L, Li Y, Liu Y. Kidney tubular beta-catenin signaling controls interstitial fibroblast fate via epithelial-mesenchymal communication. Sci Rep. 2013;3:1878. doi: 10.1038/srep01878.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep01878</ArticleId>
            <ArticleId IdType="pmc">PMC3662012</ArticleId>
            <ArticleId IdType="pubmed">23698793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Satoh W, Matsuyama M, Takemura H, Aizawa S, Shimono A. Sfrp1, Sfrp2, and Sfrp5 regulate the Wnt/beta-catenin and the planar cell polarity pathways during early trunk formation in mouse. Genesis. 2008;46:92–103. doi: 10.1002/dvg.20369.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/dvg.20369</ArticleId>
            <ArticleId IdType="pubmed">18257070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuyama M, Nomori A, Nakakuni K, Shimono A, Fukushima M. Secreted Frizzled-related protein 1 (Sfrp1) regulates the progression of renal fibrosis in a mouse model of obstructive nephropathy. J Biol Chem. 2014;289:31526–31533. doi: 10.1074/jbc.M114.584565.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M114.584565</ArticleId>
            <ArticleId IdType="pmc">PMC4223350</ArticleId>
            <ArticleId IdType="pubmed">25253698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xue H, et al.  Disruption of the Dapper3 gene aggravates ureteral obstruction-mediated renal fibrosis by amplifying Wnt/beta-catenin signaling. J Biol Chem. 2013;288:15006–15014. doi: 10.1074/jbc.M113.458448.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M113.458448</ArticleId>
            <ArticleId IdType="pmc">PMC3663521</ArticleId>
            <ArticleId IdType="pubmed">23580654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen B, et al.  Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol. 2009;5:100–107. doi: 10.1038/nchembio.137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nchembio.137</ArticleId>
            <ArticleId IdType="pmc">PMC2628455</ArticleId>
            <ArticleId IdType="pubmed">19125156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palmer HG, et al.  Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol. 2001;154:369–387.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2150773</ArticleId>
            <ArticleId IdType="pubmed">11470825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou L, et al.  Multiple genes of the renin-angiotensin system are novel targets of Wnt/beta-catenin signaling. J Am Soc Nephrol. 2015;26:107–120. doi: 10.1681/ASN.2014010085.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2014010085</ArticleId>
            <ArticleId IdType="pmc">PMC4279741</ArticleId>
            <ArticleId IdType="pubmed">25012166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DiRocco DP, Kobayashi A, Taketo MM, McMahon AP, Humphreys BD. Wnt4/beta-catenin signaling in medullary kidney myofibroblasts. J Am Soc Nephrol. 2013;24:1399–1412. doi: 10.1681/ASN.2012050512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2012050512</ArticleId>
            <ArticleId IdType="pmc">PMC3752942</ArticleId>
            <ArticleId IdType="pubmed">23766539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang P, Cai Y, Soofi A, Dressler GR. Activation of Wnt11 by transforming growth factor-beta drives mesenchymal gene expression through non-canonical Wnt protein signaling in renal epithelial cells. J Biol Chem. 2012;287:21290–21302. doi: 10.1074/jbc.M112.357202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M112.357202</ArticleId>
            <ArticleId IdType="pmc">PMC3375550</ArticleId>
            <ArticleId IdType="pubmed">22556418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kato H, et al.  Wnt/beta-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival. J Biol Chem. 2011;286:26003–26015. doi: 10.1074/jbc.M111.223164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M111.223164</ArticleId>
            <ArticleId IdType="pmc">PMC3138306</ArticleId>
            <ArticleId IdType="pubmed">21613219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dai C, et al.  Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol. 2009;20:1997–2008. doi: 10.1681/ASN.2009010019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2009010019</ArticleId>
            <ArticleId IdType="pmc">PMC2736766</ArticleId>
            <ArticleId IdType="pubmed">19628668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cain JE, Rosenblum ND. Control of mammalian kidney development by the Hedgehog signaling pathway. Pediatr Nephrol. 2011;26:1365–1371. doi: 10.1007/s00467-010-1704-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00467-010-1704-x</ArticleId>
            <ArticleId IdType="pubmed">21161287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mao J, Kim BM, Rajurkar M, Shivdasani RA, McMahon AP. Hedgehog signaling controls mesenchymal growth in the developing mammalian digestive tract. Development. 2010;137:1721–1729. doi: 10.1242/dev.044586.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.044586</ArticleId>
            <ArticleId IdType="pmc">PMC2860252</ArticleId>
            <ArticleId IdType="pubmed">20430747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao E, Chuang PT. Hedgehog signaling: From basic research to clinical applications. J Formos Med Assoc. 2015;114:569–576. doi: 10.1016/j.jfma.2015.01.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jfma.2015.01.005</ArticleId>
            <ArticleId IdType="pubmed">25701396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abidi A. Hedgehog signaling pathway: a novel target for cancer therapy: vismodegib, a promising therapeutic option in treatment of basal cell carcinomas. Indian J Pharmacol. 2014;46:3–12. doi: 10.4103/0253-7613.124884.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0253-7613.124884</ArticleId>
            <ArticleId IdType="pmc">PMC3912804</ArticleId>
            <ArticleId IdType="pubmed">24550577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katoh Y, Katoh M. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med. 2009;9:873–886.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19860666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie J, et al.  Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature. 1998;391:90–92. doi: 10.1038/34201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/34201</ArticleId>
            <ArticleId IdType="pubmed">9422511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bowers M, et al.  Limb anterior-posterior polarity integrates activator and repressor functions of GLI2 as well as GLI3. Dev Biol. 2012;370:110–124. doi: 10.1016/j.ydbio.2012.07.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ydbio.2012.07.017</ArticleId>
            <ArticleId IdType="pmc">PMC3432687</ArticleId>
            <ArticleId IdType="pubmed">22841643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Attanasio M, et al.  Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis. Nat Genet. 2007;39:1018–1024. doi: 10.1038/ng2072.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng2072</ArticleId>
            <ArticleId IdType="pubmed">17618285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li B, et al.  Increased hedgehog signaling in postnatal kidney results in aberrant activation of nephron developmental programs. Hum Mol Genet. 2011;20:4155–4166. doi: 10.1093/hmg/ddr339.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddr339</ArticleId>
            <ArticleId IdType="pmc">PMC3188992</ArticleId>
            <ArticleId IdType="pubmed">21816948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fabian SL, et al.  Hedgehog-Gli pathway activation during kidney fibrosis. Am J Pathol. 2012;180:1441–1453. doi: 10.1016/j.ajpath.2011.12.039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajpath.2011.12.039</ArticleId>
            <ArticleId IdType="pmc">PMC3349903</ArticleId>
            <ArticleId IdType="pubmed">22342522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou D, et al.  Sonic hedgehog is a novel tubule-derived growth factor for interstitial fibroblasts after kidney injury. J Am Soc Nephrol. 2014;25:2187–2200. doi: 10.1681/ASN.2013080893.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2013080893</ArticleId>
            <ArticleId IdType="pmc">PMC4178435</ArticleId>
            <ArticleId IdType="pubmed">24744439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding H, et al.  Sonic hedgehog signaling mediates epithelial-mesenchymal communication and promotes renal fibrosis. J Am Soc Nephrol. 2012;23:801–813. doi: 10.1681/ASN.2011060614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2011060614</ArticleId>
            <ArticleId IdType="pmc">PMC3338290</ArticleId>
            <ArticleId IdType="pubmed">22302193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kramann R, et al.  Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis. J Clin Invest. 2015 doi: 10.1172/JCI74929.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI74929</ArticleId>
            <ArticleId IdType="pmc">PMC4563736</ArticleId>
            <ArticleId IdType="pubmed">26193634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kramann R, et al.  Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell. 2015;16:51–66. doi: 10.1016/j.stem.2014.11.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stem.2014.11.004</ArticleId>
            <ArticleId IdType="pmc">PMC4289444</ArticleId>
            <ArticleId IdType="pubmed">25465115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schneider J, Arraf AA, Grinstein M, Yelin R, Schultheiss TM. Wnt signaling orients the proximal-distal axis of chick kidney nephrons. Development. 2015;142:2686–2695. doi: 10.1242/dev.123968.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.123968</ArticleId>
            <ArticleId IdType="pubmed">26116665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haegebarth A, Clevers H. Wnt signaling, lgr5, and stem cells in the intestine and skin. Am J Pathol. 2009;174:715–721. doi: 10.2353/ajpath.2009.080758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2353/ajpath.2009.080758</ArticleId>
            <ArticleId IdType="pmc">PMC2665733</ArticleId>
            <ArticleId IdType="pubmed">19197002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krausova M, Korinek V. Wnt signaling in adult intestinal stem cells and cancer. Cell Signal. 2014;26:570–579. doi: 10.1016/j.cellsig.2013.11.032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellsig.2013.11.032</ArticleId>
            <ArticleId IdType="pubmed">24308963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vooijs M, Liu Z, Kopan R. Notch: architect, landscaper, and guardian of the intestine. Gastroenterology. 2011;141:448–459. doi: 10.1053/j.gastro.2011.06.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2011.06.003</ArticleId>
            <ArticleId IdType="pmc">PMC4050496</ArticleId>
            <ArticleId IdType="pubmed">21689653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van der Flier LG, Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol. 2009;71:241–260. doi: 10.1146/annurev.physiol.010908.163145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.physiol.010908.163145</ArticleId>
            <ArticleId IdType="pubmed">18808327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao Z, et al.  Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis. Nature medicine. 2016;22:154–162. doi: 10.1038/nm.4035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.4035</ArticleId>
            <ArticleId IdType="pmc">PMC4872630</ArticleId>
            <ArticleId IdType="pubmed">26779814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005;434:843–850. doi: 10.1038/nature03319.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature03319</ArticleId>
            <ArticleId IdType="pubmed">15829953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kramann R, et al.  Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis. The Journal of clinical investigation. 2015;125:2935–2951. doi: 10.1172/JCI74929.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI74929</ArticleId>
            <ArticleId IdType="pmc">PMC4563736</ArticleId>
            <ArticleId IdType="pubmed">26193634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobayashi T, et al.  Expression and function of the Delta-1/Notch-2/Hes-1 pathway during experimental acute kidney injury. Kidney Int. 2008;73:1240–1250. doi: 10.1038/ki.2008.74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2008.74</ArticleId>
            <ArticleId IdType="pubmed">18418349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta S, et al.  Effect of Notch activation on the regenerative response to acute renal failure. Am J Physiol Renal Physiol. 2010;298:F209–215. doi: 10.1152/ajprenal.00451.2009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.00451.2009</ArticleId>
            <ArticleId IdType="pubmed">19828677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walsh DW, et al.  Co-regulation of Gremlin and Notch signalling in diabetic nephropathy. Biochimica et biophysica acta. 2008;1782:10–21. doi: 10.1016/j.bbadis.2007.09.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbadis.2007.09.005</ArticleId>
            <ArticleId IdType="pubmed">17980714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simic D, et al.  Determination of relative Notch1 and gamma-secretase-related gene expression in puromycin-treated microdissected rat kidneys. Gene Expr. 2013;16:39–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24397211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Surendran K, McCaul SP, Simon TC. A role for Wnt-4 in renal fibrosis. Am J Physiol Renal Physiol. 2002;282:F431–441. doi: 10.1152/ajprenal.0009.2001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.0009.2001</ArticleId>
            <ArticleId IdType="pubmed">11832423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuma A, et al.  Role of WNT10A-expressing kidney fibroblasts in acute interstitial nephritis. PLoS One. 2014;9:e103240. doi: 10.1371/journal.pone.0103240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0103240</ArticleId>
            <ArticleId IdType="pmc">PMC4108433</ArticleId>
            <ArticleId IdType="pubmed">25054240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim MK, et al.  The differential expression of TGF-beta1, ILK and wnt signaling inducing epithelial to mesenchymal transition in human renal fibrogenesis: an immunohistochemical study. Int J Clin Exp Pathol. 2013;6:1747–1758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3759481</ArticleId>
            <ArticleId IdType="pubmed">24040439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang D, Dai C, Li Y, Liu Y. Canonical Wnt/beta-catenin signaling mediates transforming growth factor-beta1-driven podocyte injury and proteinuria. Kidney Int. 2011;80:1159–1169. doi: 10.1038/ki.2011.255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2011.255</ArticleId>
            <ArticleId IdType="pmc">PMC4300105</ArticleId>
            <ArticleId IdType="pubmed">21832980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang L, et al.  Calmodulin-dependent protein kinase II/cAMP response element-binding protein/Wnt/beta-catenin signaling cascade regulates angiotensin II-induced podocyte injury and albuminuria. J Biol Chem. 2013;288:23368–23379. doi: 10.1074/jbc.M113.460394.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M113.460394</ArticleId>
            <ArticleId IdType="pmc">PMC3743506</ArticleId>
            <ArticleId IdType="pubmed">23803607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren S, et al.  LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1. Proc Natl Acad Sci U S A. 2013;110:1440–1445. doi: 10.1073/pnas.1211179110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1211179110</ArticleId>
            <ArticleId IdType="pmc">PMC3557093</ArticleId>
            <ArticleId IdType="pubmed">23302695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hao S, et al.  Targeted inhibition of beta-catenin/CBP signaling ameliorates renal interstitial fibrosis. J Am Soc Nephrol. 2011;22:1642–1653. doi: 10.1681/ASN.2010101079.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2010101079</ArticleId>
            <ArticleId IdType="pmc">PMC3171936</ArticleId>
            <ArticleId IdType="pubmed">21816937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He W, Kang YS, Dai C, Liu Y. Blockade of Wnt/beta-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J Am Soc Nephrol. 2011;22:90–103. doi: 10.1681/ASN.2009121236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2009121236</ArticleId>
            <ArticleId IdType="pmc">PMC3014038</ArticleId>
            <ArticleId IdType="pubmed">21030600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Surendran K, Schiavi S, Hruska KA. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol. 2005;16:2373–2384. doi: 10.1681/ASN.2004110949.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2004110949</ArticleId>
            <ArticleId IdType="pubmed">15944336</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">27140856</PMID>
      <DateCompleted>
        <Year>2017</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1759-507X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>12</Volume>
            <Issue>7</Issue>
            <PubDate>
              <Year>2016</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nature reviews. Nephrology</Title>
          <ISOAbbreviation>Nat Rev Nephrol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog.</ArticleTitle>
        <Pagination>
          <StartPage>426</StartPage>
          <EndPage>439</EndPage>
          <MedlinePgn>426-39</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/nrneph.2016.54</ELocationID>
        <Abstract>
          <AbstractText>Kidney fibrosis is a common histological manifestation of functional decline in the kidney. Fibrosis is a reactive process that develops in response to excessive epithelial injury and inflammation, leading to myofibroblast activation and an accumulation of extracellular matrix. Here, we describe how three key developmental signalling pathways - Notch, Wnt and Hedgehog (Hh) - are reactivated in response to kidney injury and contribute to the fibrotic response. Although transient activation of these pathways is needed for repair of injured tissue, their sustained activation is thought to promote fibrosis. Excessive Wnt and Notch expression prohibit epithelial differentiation, whereas increased Wnt and Hh expression induce fibroblast proliferation and myofibroblastic transdifferentiation. Notch, Wnt and Hh are fundamentally different signalling pathways, but their choreographed activation seems to be just as important for fibrosis as it is for embryonic kidney development. Decreasing the activity of Notch, Wnt or Hh signalling could potentially provide a new therapeutic strategy to ameliorate the development of fibrosis in chronic kidney disease.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Edeling</LastName>
            <ForeName>Maria</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Renal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 415 Curie Boulevard, 415 Clinical Research Building, Philadelphia, Pennsylvania 19104, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Nephrology, Internal Medicine D, University Hospital Albert-Schweitzer-Straße 33, Münster 48149, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ragi</LastName>
            <ForeName>Grace</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Renal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 415 Curie Boulevard, 415 Clinical Research Building, Philadelphia, Pennsylvania 19104, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Shizheng</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Renal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 415 Curie Boulevard, 415 Clinical Research Building, Philadelphia, Pennsylvania 19104, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pavenstädt</LastName>
            <ForeName>Hermann</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Nephrology, Internal Medicine D, University Hospital Albert-Schweitzer-Straße 33, Münster 48149, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Susztak</LastName>
            <ForeName>Katalin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Renal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 415 Curie Boulevard, 415 Clinical Research Building, Philadelphia, Pennsylvania 19104, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>DP3 DK108220</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK076077</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK087635</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK105821</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2016</Year>
          <Month>05</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Nat Rev Nephrol</MedlineTA>
        <NlmUniqueID>101500081</NlmUniqueID>
        <ISSNLinking>1759-5061</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053823">Hedgehog Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051880">Receptors, Notch</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053823" MajorTopicYN="N">Hedgehog Proteins</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050199" MajorTopicYN="N">Podocytes</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051880" MajorTopicYN="N">Receptors, Notch</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060449" MajorTopicYN="N">Wnt Signaling Pathway</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement><b>Competing interests</b>. The Susztaklab received research support from Boehringer Ingelheim, Biogen and Lilly.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2017</Year>
          <Month>5</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">27140856</ArticleId>
        <ArticleId IdType="mid">NIHMS876485</ArticleId>
        <ArticleId IdType="pmc">PMC5529143</ArticleId>
        <ArticleId IdType="doi">10.1038/nrneph.2016.54</ArticleId>
        <ArticleId IdType="pii">nrneph.2016.54</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Jha V. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260–272. doi: 10.1016/S0140-6736(13)60687-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(13)60687-X</ArticleId>
            <ArticleId IdType="pubmed">23727169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 2006;69:213–217. doi: 10.1038/sj.ki.5000054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.ki.5000054</ArticleId>
            <ArticleId IdType="pubmed">16408108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tonelli M, et al.  Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17:2034–2047. doi: 10.1681/ASN.2005101085.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2005101085</ArticleId>
            <ArticleId IdType="pubmed">16738019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reidy K, Kang HM, Hostetter T, Susztak K. Molecular mechanisms of diabetic kidney disease. J Clin Invest. 2014;124:2333–2340. doi: 10.1172/JCI72271.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI72271</ArticleId>
            <ArticleId IdType="pmc">PMC4089448</ArticleId>
            <ArticleId IdType="pubmed">24892707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duffield JS. Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest. 2014;124:2299–2306. doi: 10.1172/JCI72267.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI72267</ArticleId>
            <ArticleId IdType="pmc">PMC4038570</ArticleId>
            <ArticleId IdType="pubmed">24892703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol. 2011;7:684–696. doi: 10.1038/nrneph.2011.149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrneph.2011.149</ArticleId>
            <ArticleId IdType="pmc">PMC4520424</ArticleId>
            <ArticleId IdType="pubmed">22009250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaissling B, Lehir M, Kriz W. Renal epithelial injury and fibrosis. Biochim Biophys Acta. 2013;1832:931–939. doi: 10.1016/j.bbadis.2013.02.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbadis.2013.02.010</ArticleId>
            <ArticleId IdType="pubmed">23466594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grgic I, Duffield JS, Humphreys BD. The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol. 2012;27:183–193. doi: 10.1007/s00467-011-1772-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00467-011-1772-6</ArticleId>
            <ArticleId IdType="pmc">PMC3116994</ArticleId>
            <ArticleId IdType="pubmed">21311912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Humphreys BD, et al.  Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol. 2010;176:85–97. doi: 10.2353/ajpath.2010.090517.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2353/ajpath.2010.090517</ArticleId>
            <ArticleId IdType="pmc">PMC2797872</ArticleId>
            <ArticleId IdType="pubmed">20008127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woroniecka KI, et al.  Transcriptome analysis of human diabetic kidney disease. Diabetes. 2011;60:2354–2369. doi: 10.2337/db10-1181.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db10-1181</ArticleId>
            <ArticleId IdType="pmc">PMC3161334</ArticleId>
            <ArticleId IdType="pubmed">21752957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Susztak K, Raff AC, Schiffer M, Bottinger EP. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes. 2006;55:225–233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16380497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huber TB, et al.  Emerging role of autophagy in kidney function, diseases and aging. Autophagy. 2012;8:1009–1031. doi: 10.4161/auto.19821.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/auto.19821</ArticleId>
            <ArticleId IdType="pmc">PMC3429540</ArticleId>
            <ArticleId IdType="pubmed">22692002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lieberthal W, Levine JS. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am J Physiol. 1996;271:F477–488.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8853409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ueda N, Kaushal GP, Shah SV. Recent advances in understanding mechanisms of renal tubular injury. Adv Ren Replace Ther. 1997;4:17–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9113237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lieberthal W, Koh JS, Levine JS. Necrosis and apoptosis in acute renal failure. Semin Nephrol. 1998;18:505–518.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9754603</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petermann A, Floege J. Podocyte damage resulting in podocyturia: a potential diagnostic marker to assess glomerular disease activity. Nephron Clin Pract. 2007;106:c61–66. doi: 10.1159/000101799.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000101799</ArticleId>
            <ArticleId IdType="pubmed">17570931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest. 2011;121:4210–4221. doi: 10.1172/JCI45161.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI45161</ArticleId>
            <ArticleId IdType="pmc">PMC3204829</ArticleId>
            <ArticleId IdType="pubmed">22045571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hakroush S, et al.  Extensive podocyte loss triggers a rapid parietal epithelial cell response. J Am Soc Nephrol. 2014;25:927–938. doi: 10.1681/ASN.2013070687.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2013070687</ArticleId>
            <ArticleId IdType="pmc">PMC4005306</ArticleId>
            <ArticleId IdType="pubmed">24335975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eng DG, et al.  Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis. Kidney Int. 2015;88:999–1012. doi: 10.1038/ki.2015.152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2015.152</ArticleId>
            <ArticleId IdType="pmc">PMC4654724</ArticleId>
            <ArticleId IdType="pubmed">25993321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wharram BL, et al.  Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol. 2005;16:2941–2952. doi: 10.1681/ASN.2005010055.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2005010055</ArticleId>
            <ArticleId IdType="pubmed">16107576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rutkowski JM, et al.  Adiponectin promotes functional recovery after podocyte ablation. J Am Soc Nephrol. 2013;24:268–282. doi: 10.1681/ASN.2012040414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2012040414</ArticleId>
            <ArticleId IdType="pmc">PMC3559480</ArticleId>
            <ArticleId IdType="pubmed">23334396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inoki K, et al.  mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest. 2011;121:2181–2196. doi: 10.1172/JCI44771.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI44771</ArticleId>
            <ArticleId IdType="pmc">PMC3104745</ArticleId>
            <ArticleId IdType="pubmed">21606597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Godel M, et al.  Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest. 2011;121:2197–2209. doi: 10.1172/JCI44774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI44774</ArticleId>
            <ArticleId IdType="pmc">PMC3104746</ArticleId>
            <ArticleId IdType="pubmed">21606591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wiggins JE, et al.  Podocyte hypertrophy, “adaptation,” and “decompensation” associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol. 2005;16:2953–2966. doi: 10.1681/ASN.2005050488.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2005050488</ArticleId>
            <ArticleId IdType="pubmed">16120818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pagtalunan ME, et al.  Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest. 1997;99:342–348. doi: 10.1172/JCI119163.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI119163</ArticleId>
            <ArticleId IdType="pmc">PMC507802</ArticleId>
            <ArticleId IdType="pubmed">9006003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes. 2005;54:1626–1634.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15919782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dimke H, et al.  Tubulovascular Cross-Talk by Vascular Endothelial Growth Factor A Maintains Peritubular Microvasculature in Kidney. J Am Soc Nephrol. 2014 doi: 10.1681/ASN.2014010060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2014010060</ArticleId>
            <ArticleId IdType="pmc">PMC4413754</ArticleId>
            <ArticleId IdType="pubmed">25385849</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol. 2005;15:599–607. doi: 10.1016/j.tcb.2005.09.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tcb.2005.09.002</ArticleId>
            <ArticleId IdType="pubmed">16202600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gu L, et al.  Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy. AIDS. 2013;27:1091–1098. doi: 10.1097/QAD.0b013e32835f1ea1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/QAD.0b013e32835f1ea1</ArticleId>
            <ArticleId IdType="pmc">PMC3918880</ArticleId>
            <ArticleId IdType="pubmed">23343908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dai Y, et al.  Podocyte-specific deletion of signal transducer and activator of transcription 3 attenuates nephrotoxic serum-induced glomerulonephritis. Kidney Int. 2013;84:950–961. doi: 10.1038/ki.2013.197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2013.197</ArticleId>
            <ArticleId IdType="pmc">PMC3797218</ArticleId>
            <ArticleId IdType="pubmed">23842188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 2001;107:7–11. doi: 10.1172/JCI11830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI11830</ArticleId>
            <ArticleId IdType="pmc">PMC198552</ArticleId>
            <ArticleId IdType="pubmed">11134171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng XM, Nikolic-Paterson DJ, Lan HY. Inflammatory processes in renal fibrosis. Nat Rev Nephrol. 2014;10:493–503. doi: 10.1038/nrneph.2014.114.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrneph.2014.114</ArticleId>
            <ArticleId IdType="pubmed">24981817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar D, Singla SK, Puri V, Puri S. The restrained expression of NF-kB in renal tissue ameliorates folic acid induced acute kidney injury in mice. PLoS One. 2015;10:e115947. doi: 10.1371/journal.pone.0115947.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0115947</ArticleId>
            <ArticleId IdType="pmc">PMC4283964</ArticleId>
            <ArticleId IdType="pubmed">25559736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okabe C, et al.  NF-kappaB activation mediates crystal translocation and interstitial inflammation in adenine overload nephropathy. Am J Physiol Renal Physiol. 2013;305:F155–163. doi: 10.1152/ajprenal.00491.2012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.00491.2012</ArticleId>
            <ArticleId IdType="pubmed">23657853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yukawa K, et al.  STAT6 deficiency inhibits tubulointerstitial fibrosis in obstructive nephropathy. Int J Mol Med. 2005;15:225–230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15647835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedman SL, Sheppard D, Duffield JS, Violette S. Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med. 2013;5:167sr161. doi: 10.1126/scitranslmed.3004700.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scitranslmed.3004700</ArticleId>
            <ArticleId IdType="pubmed">23303606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meran S, Steadman R. Fibroblasts and myofibroblasts in renal fibrosis. Int J Exp Pathol. 2011;92:158–167. doi: 10.1111/j.1365-2613.2011.00764.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2613.2011.00764.x</ArticleId>
            <ArticleId IdType="pmc">PMC3101489</ArticleId>
            <ArticleId IdType="pubmed">21355940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu B, Phan SH. Myofibroblasts. Curr Opin Rheumatol. 2013;25:71–77. doi: 10.1097/BOR.0b013e32835b1352.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/BOR.0b013e32835b1352</ArticleId>
            <ArticleId IdType="pmc">PMC4007118</ArticleId>
            <ArticleId IdType="pubmed">23114586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kendall RT, Feghali-Bostwick CA. Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol. 2014;5:123. doi: 10.3389/fphar.2014.00123.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2014.00123</ArticleId>
            <ArticleId IdType="pmc">PMC4034148</ArticleId>
            <ArticleId IdType="pubmed">24904424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klingberg F, Hinz B, White ES. The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol. 2013;229:298–309. doi: 10.1002/path.4104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/path.4104</ArticleId>
            <ArticleId IdType="pmc">PMC4005341</ArticleId>
            <ArticleId IdType="pubmed">22996908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wight TN, Potter-Perigo S. The extracellular matrix: an active or passive player in fibrosis. Am J Physiol Gastrointest Liver Physiol. 2011;301:G950–955. doi: 10.1152/ajpgi.00132.2011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpgi.00132.2011</ArticleId>
            <ArticleId IdType="pmc">PMC3233785</ArticleId>
            <ArticleId IdType="pubmed">21512158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olsen AL, et al.  Hepatic stellate cells require a stiff environment for myofibroblastic differentiation. Am J Physiol Gastrointest Liver Physiol. 2011;301:G110–118. doi: 10.1152/ajpgi.00412.2010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpgi.00412.2010</ArticleId>
            <ArticleId IdType="pmc">PMC3129929</ArticleId>
            <ArticleId IdType="pubmed">21527725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Urban ML, Manenti L, Vaglio A. Fibrosis–A Common Pathway to Organ Injury and Failure. N Engl J Med. 2015;373:95–96. doi: 10.1056/NEJMc1504848#SA2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc1504848#SA2</ArticleId>
            <ArticleId IdType="pubmed">26132961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest. 2007;117:524–529. doi: 10.1172/JCI31487.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI31487</ArticleId>
            <ArticleId IdType="pmc">PMC1804380</ArticleId>
            <ArticleId IdType="pubmed">17332879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lavoz C, et al.  Angiotensin II contributes to renal fibrosis independently of Notch pathway activation. PLoS One. 2012;7:e40490. doi: 10.1371/journal.pone.0040490.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0040490</ArticleId>
            <ArticleId IdType="pmc">PMC3392235</ArticleId>
            <ArticleId IdType="pubmed">22792351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boor P, Floege J. Chronic kidney disease growth factors in renal fibrosis. Clin Exp Pharmacol Physiol. 2011;38:441–450. doi: 10.1111/j.1440-1681.2011.05487.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1440-1681.2011.05487.x</ArticleId>
            <ArticleId IdType="pubmed">21276040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chuang PY, Menon MC, He JC. Molecular targets for treatment of kidney fibrosis. J Mol Med (Berl) 2013;91:549–559. doi: 10.1007/s00109-012-0983-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00109-012-0983-z</ArticleId>
            <ArticleId IdType="pmc">PMC3594378</ArticleId>
            <ArticleId IdType="pubmed">23179685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shull MM, et al.  Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992;359:693–699. doi: 10.1038/359693a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/359693a0</ArticleId>
            <ArticleId IdType="pmc">PMC3889166</ArticleId>
            <ArticleId IdType="pubmed">1436033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kulkarni AB, et al.  Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A. 1993;90:770–774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC45747</ArticleId>
            <ArticleId IdType="pubmed">8421714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai EC. Notch signaling: control of cell communication and cell fate. Development. 2004;131:965–973. doi: 10.1242/dev.01074.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.01074</ArticleId>
            <ArticleId IdType="pubmed">14973298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ilagan MX, Lim S, Fulbright M, Piwnica-Worms D, Kopan R. Real-time imaging of notch activation with a luciferase complementation-based reporter. Sci Signal. 2011;4:rs7. doi: 10.1126/scisignal.2001656.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scisignal.2001656</ArticleId>
            <ArticleId IdType="pmc">PMC3387985</ArticleId>
            <ArticleId IdType="pubmed">21775282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137:216–233. doi: 10.1016/j.cell.2009.03.045.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2009.03.045</ArticleId>
            <ArticleId IdType="pmc">PMC2827930</ArticleId>
            <ArticleId IdType="pubmed">19379690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sirin Y, Susztak K. Notch in the kidney: development and disease. J Pathol. 2012;226:394–403. doi: 10.1002/path.2967.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/path.2967</ArticleId>
            <ArticleId IdType="pmc">PMC3677191</ArticleId>
            <ArticleId IdType="pubmed">21952830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Penton AL, Leonard LD, Spinner NB. Notch signaling in human development and disease. Semin Cell Dev Biol. 2012;23:450–457. doi: 10.1016/j.semcdb.2012.01.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semcdb.2012.01.010</ArticleId>
            <ArticleId IdType="pmc">PMC3638987</ArticleId>
            <ArticleId IdType="pubmed">22306179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng HT, et al.  Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development. 2007;134:801–811. doi: 10.1242/dev.02773.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.02773</ArticleId>
            <ArticleId IdType="pmc">PMC2613851</ArticleId>
            <ArticleId IdType="pubmed">17229764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujimura S, Jiang Q, Kobayashi C, Nishinakamura R. Notch2 activation in the embryonic kidney depletes nephron progenitors. J Am Soc Nephrol. 2010;21:803–810. doi: 10.1681/ASN.2009040353.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2009040353</ArticleId>
            <ArticleId IdType="pmc">PMC2865736</ArticleId>
            <ArticleId IdType="pubmed">20299358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Djudjaj S, et al.  Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury. J Pathol. 2012;228:286–299. doi: 10.1002/path.4076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/path.4076</ArticleId>
            <ArticleId IdType="pubmed">22806125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma S, Sirin Y, Susztak K. The story of Notch and chronic kidney disease. Curr Opin Nephrol Hypertens. 2011;20:56–61. doi: 10.1097/MNH.0b013e3283414c88.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MNH.0b013e3283414c88</ArticleId>
            <ArticleId IdType="pmc">PMC3164509</ArticleId>
            <ArticleId IdType="pubmed">21088575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carulli AJ, et al.  Notch receptor regulation of intestinal stem cell homeostasis and crypt regeneration. Dev Biol. 2015;402:98–108. doi: 10.1016/j.ydbio.2015.03.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ydbio.2015.03.012</ArticleId>
            <ArticleId IdType="pmc">PMC4433599</ArticleId>
            <ArticleId IdType="pubmed">25835502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barker N, et al.  Lgr5(+ve) stem/progenitor cells contribute to nephron formation during kidney development. Cell Rep. 2012;2:540–552. doi: 10.1016/j.celrep.2012.08.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2012.08.018</ArticleId>
            <ArticleId IdType="pubmed">22999937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pleniceanu O, Harari-Steinberg O, Dekel B. Concise review: Kidney stem/progenitor cells: differentiate, sort out, or reprogram. Stem Cells. 2010;28:1649–1660. doi: 10.1002/stem.486.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/stem.486</ArticleId>
            <ArticleId IdType="pmc">PMC2996087</ArticleId>
            <ArticleId IdType="pubmed">20652959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar S, et al.  Sox9 Activation Highlights a Cellular Pathway of Renal Repair in the Acutely Injured Mammalian Kidney. Cell Rep. 2015;12:1325–1338. doi: 10.1016/j.celrep.2015.07.034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2015.07.034</ArticleId>
            <ArticleId IdType="pubmed">26279573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reginensi A, et al.  SOX9 controls epithelial branching by activating RET effector genes during kidney development. Hum Mol Genet. 2011;20:1143–1153. doi: 10.1093/hmg/ddq558.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddq558</ArticleId>
            <ArticleId IdType="pmc">PMC3809456</ArticleId>
            <ArticleId IdType="pubmed">21212101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang HM, et al.  Sox9-Positive Progenitor Cells Play a Key Role in Renal Tubule Epithelial Regeneration in Mice. Cell Rep. 2016;14:861–871. doi: 10.1016/j.celrep.2015.12.071.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2015.12.071</ArticleId>
            <ArticleId IdType="pmc">PMC4854207</ArticleId>
            <ArticleId IdType="pubmed">26776520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomez RA, Belyea B, Medrano S, Pentz ES, Sequeira-Lopez ML. Fate and plasticity of renin precursors in development and disease. Pediatr Nephrol. 2014;29:721–726. doi: 10.1007/s00467-013-2688-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00467-013-2688-0</ArticleId>
            <ArticleId IdType="pmc">PMC3999616</ArticleId>
            <ArticleId IdType="pubmed">24337407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bussolati B, et al.  Isolation of renal progenitor cells from adult human kidney. Am J Pathol. 2005;166(10):545–555. 62276–6. doi: 10.1016/S0002-9440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0002-9440</ArticleId>
            <ArticleId IdType="pmc">PMC1602314</ArticleId>
            <ArticleId IdType="pubmed">15681837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J, Chen JK, Conway EM, Harris RC. Survivin mediates renal proximal tubule recovery from AKI. J Am Soc Nephrol. 2013;24:2023–2033. doi: 10.1681/ASN.2013010076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2013010076</ArticleId>
            <ArticleId IdType="pmc">PMC3839548</ArticleId>
            <ArticleId IdType="pubmed">23949800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang R, Zhou Q, Veeraragoo P, Yu H, Xiao Z. Notch2/Hes-1 pathway plays an important role in renal ischemia and reperfusion injury-associated inflammation and apoptosis and the gamma-secretase inhibitor DAPT has a nephroprotective effect. Ren Fail. 2011;33:207–216. doi: 10.3109/0886022X.2011.553979.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/0886022X.2011.553979</ArticleId>
            <ArticleId IdType="pubmed">21332343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sorensen-Zender I, et al.  Renal tubular Notch signaling triggers a prosenescent state after acute kidney injury. Am J Physiol Renal Physiol. 2014;306:F907–915. doi: 10.1152/ajprenal.00030.2014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.00030.2014</ArticleId>
            <ArticleId IdType="pubmed">24573392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murea M, et al.  Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. Kidney Int. 2010;78:514–522. doi: 10.1038/ki.2010.172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2010.172</ArticleId>
            <ArticleId IdType="pmc">PMC3164583</ArticleId>
            <ArticleId IdType="pubmed">20531454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bielesz B, et al.  Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest. 2010;120:4040–4054. doi: 10.1172/JCI43025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI43025</ArticleId>
            <ArticleId IdType="pmc">PMC2964979</ArticleId>
            <ArticleId IdType="pubmed">20978353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, Li Y, Kong D, Sarkar FH. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Curr Drug Targets. 2010;11:745–751.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3084452</ArticleId>
            <ArticleId IdType="pubmed">20041844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saad S, Stanners SR, Yong R, Tang O, Pollock CA. Notch mediated epithelial to mesenchymal transformation is associated with increased expression of the Snail transcription factor. Int J Biochem Cell Biol. 2010;42:1115–1122. doi: 10.1016/j.biocel.2010.03.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biocel.2010.03.016</ArticleId>
            <ArticleId IdType="pubmed">20348013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grande MT, et al.  Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat Med. 2015;21:989–997. doi: 10.1038/nm.3901.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.3901</ArticleId>
            <ArticleId IdType="pubmed">26236989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lovisa S, et al.  Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat Med. 2015;21:998–1009. doi: 10.1038/nm.3902.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.3902</ArticleId>
            <ArticleId IdType="pmc">PMC4587560</ArticleId>
            <ArticleId IdType="pubmed">26236991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lasagni L, et al.  Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. Stem Cells. 2010;28:1674–1685. doi: 10.1002/stem.492.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/stem.492</ArticleId>
            <ArticleId IdType="pmc">PMC2996085</ArticleId>
            <ArticleId IdType="pubmed">20680961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen L, Al-Awqati Q. Segmental expression of Notch and Hairy genes in nephrogenesis. Am J Physiol Renal Physiol. 2005;288:F939–952. doi: 10.1152/ajprenal.00369.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.00369.2004</ArticleId>
            <ArticleId IdType="pubmed">15821257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barak H, Surendran K, Boyle SC. The role of Notch signaling in kidney development and disease. Adv Exp Med Biol. 2012;727:99–113. doi: 10.1007/978-1-4614-0899-4_8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-4614-0899-4_8</ArticleId>
            <ArticleId IdType="pubmed">22399342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bielefeld KA, Amini-Nik S, Alman BA. Cutaneous wound healing: recruiting developmental pathways for regeneration. Cell Mol Life Sci. 2013;70:2059–2081. doi: 10.1007/s00018-012-1152-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-012-1152-9</ArticleId>
            <ArticleId IdType="pmc">PMC3663196</ArticleId>
            <ArticleId IdType="pubmed">23052205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao Z, et al.  The Notch gamma-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-beta/Smad2/3 signaling pathway activation. Int J Biochem Cell Biol. 2014;55:65–71. doi: 10.1016/j.biocel.2014.08.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biocel.2014.08.009</ArticleId>
            <ArticleId IdType="pubmed">25150830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takebe N, Harris PJ, Warren RQ, Ivy SP. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol. 2011;8:97–106. doi: 10.1038/nrclinonc.2010.196.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrclinonc.2010.196</ArticleId>
            <ArticleId IdType="pubmed">21151206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayward P, Kalmar T, Arias AM. Wnt/Notch signalling and information processing during development. Development. 2008;135:411–424. doi: 10.1242/dev.000505.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.000505</ArticleId>
            <ArticleId IdType="pubmed">18192283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niranjan T, et al.  The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med. 2008;14:290–298. doi: 10.1038/nm1731.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm1731</ArticleId>
            <ArticleId IdType="pubmed">18311147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niranjan T, Murea M, Susztak K. The pathogenic role of Notch activation in podocytes. Nephron Exp Nephrol. 2009;111:e73–79. doi: 10.1159/000209207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000209207</ArticleId>
            <ArticleId IdType="pmc">PMC2851161</ArticleId>
            <ArticleId IdType="pubmed">19293596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin CL, et al.  Modulation of notch-1 signaling alleviates vascular endothelial growth factor-mediated diabetic nephropathy. Diabetes. 2010;59:1915–1925. doi: 10.2337/db09-0663.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db09-0663</ArticleId>
            <ArticleId IdType="pmc">PMC2911050</ArticleId>
            <ArticleId IdType="pubmed">20522599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanaka E, et al.  Notch2 activation ameliorates nephrosis. Nat Commun. 2014;5:3296. doi: 10.1038/ncomms4296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms4296</ArticleId>
            <ArticleId IdType="pubmed">24526233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arking DE, et al.  Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization. Nat Genet. 2014;46:826–836. doi: 10.1038/ng.3014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng.3014</ArticleId>
            <ArticleId IdType="pmc">PMC4124521</ArticleId>
            <ArticleId IdType="pubmed">24952745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sweetwyne MT, et al.  Notch1 and Notch2 in Podocytes Play Differential Roles During Diabetic Nephropathy Development. Diabetes. 2015;64:4099–4111. doi: 10.2337/db15-0260.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db15-0260</ArticleId>
            <ArticleId IdType="pmc">PMC4657584</ArticleId>
            <ArticleId IdType="pubmed">26293507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El Machhour F, Keuylian Z, Kavvadas P, Dussaule JC, Chatziantoniou C. Activation of Notch3 in Glomeruli Promotes the Development of Rapidly Progressive Renal Disease. J Am Soc Nephrol. 2015;26:1561–1575. doi: 10.1681/ASN.2013090968.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2013090968</ArticleId>
            <ArticleId IdType="pmc">PMC4483574</ArticleId>
            <ArticleId IdType="pubmed">25421557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nusse R, Varmus H. Three decades of Wnts: a personal perspective on how a scientific field developed. EMBO J. 2012;31:2670–2684. doi: 10.1038/emboj.2012.146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/emboj.2012.146</ArticleId>
            <ArticleId IdType="pmc">PMC3380217</ArticleId>
            <ArticleId IdType="pubmed">22617420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sokol SY. Spatial and temporal aspects of Wnt signaling and planar cell polarity during vertebrate embryonic development. Semin Cell Dev Biol. 2015;42:78–85. doi: 10.1016/j.semcdb.2015.05.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semcdb.2015.05.002</ArticleId>
            <ArticleId IdType="pmc">PMC4562884</ArticleId>
            <ArticleId IdType="pubmed">25986055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kahn M. Can we safely target the WNT pathway. Nat Rev Drug Discov. 2014;13:513–532. doi: 10.1038/nrd4233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrd4233</ArticleId>
            <ArticleId IdType="pmc">PMC4426976</ArticleId>
            <ArticleId IdType="pubmed">24981364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holland JD, Klaus A, Garratt AN, Birchmeier W. Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol. 2013;25:254–264. doi: 10.1016/j.ceb.2013.01.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ceb.2013.01.004</ArticleId>
            <ArticleId IdType="pubmed">23347562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo Y, Xiao L, Sun L, Liu F. Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. Physiol Res. 2012;61:337–346.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22670697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He X, Semenov M, Tamai K, Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development. 2004;131:1663–1677. doi: 10.1242/dev.01117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.01117</ArticleId>
            <ArticleId IdType="pubmed">15084453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moon RT, Kohn AD, De Ferrari GV, Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet. 2004;5:691–701. doi: 10.1038/nrg1427.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrg1427</ArticleId>
            <ArticleId IdType="pubmed">15372092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boyle SC, Kim M, Valerius MT, McMahon AP, Kopan R. Notch pathway activation can replace the requirement for Wnt4 and Wnt9b in mesenchymal-to-epithelial transition of nephron stem cells. Development. 2011;138:4245–4254. doi: 10.1242/dev.070433.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.070433</ArticleId>
            <ArticleId IdType="pmc">PMC3171224</ArticleId>
            <ArticleId IdType="pubmed">21852398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosenberg SL, Chen S, McLaughlin N, El-Dahr SS. Regulation of kidney development by histone deacetylases. Pediatr Nephrol. 2011;26:1445–1452. doi: 10.1007/s00467-011-1796-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00467-011-1796-y</ArticleId>
            <ArticleId IdType="pmc">PMC3199300</ArticleId>
            <ArticleId IdType="pubmed">21336812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawakami T, Ren S, Duffield JS. Wnt signalling in kidney diseases: dual roles in renal injury and repair. J Pathol. 2013;229:221–231. doi: 10.1002/path.4121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/path.4121</ArticleId>
            <ArticleId IdType="pubmed">23097132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliver JA, Maarouf O, Cheema FH, Martens TP, Al-Awqati Q. The renal papilla is a niche for adult kidney stem cells. J Clin Invest. 2004;114:795–804. doi: 10.1172/JCI20921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI20921</ArticleId>
            <ArticleId IdType="pmc">PMC516259</ArticleId>
            <ArticleId IdType="pubmed">15372103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rinkevich Y, et al.  In vivo clonal analysis reveals lineage-restricted progenitor characteristics in mammalian kidney development, maintenance, and regeneration. Cell Rep. 2014;7:1270–1283. doi: 10.1016/j.celrep.2014.04.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2014.04.018</ArticleId>
            <ArticleId IdType="pmc">PMC4425291</ArticleId>
            <ArticleId IdType="pubmed">24835991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin SL, et al.  Macrophage Wnt7b is critical for kidney repair and regeneration. Proc Natl Acad Sci U S A. 2010;107:4194–4199. doi: 10.1073/pnas.0912228107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0912228107</ArticleId>
            <ArticleId IdType="pmc">PMC2840080</ArticleId>
            <ArticleId IdType="pubmed">20160075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao L, et al.  Sustained Activation of Wnt/beta-Catenin Signaling Drives AKI to CKD Progression. J Am Soc Nephrol. 2015 doi: 10.1681/ASN.2015040449.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2015040449</ArticleId>
            <ArticleId IdType="pmc">PMC4884114</ArticleId>
            <ArticleId IdType="pubmed">26453613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terada Y, et al.  Expression and function of the developmental gene Wnt-4 during experimental acute renal failure in rats. J Am Soc Nephrol. 2003;14:1223–1233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12707392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou D, et al.  Tubule-specific ablation of endogenous beta-catenin aggravates acute kidney injury in mice. Kidney Int. 2012;82:537–547. doi: 10.1038/ki.2012.173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2012.173</ArticleId>
            <ArticleId IdType="pmc">PMC3425732</ArticleId>
            <ArticleId IdType="pubmed">22622501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He W, et al.  Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol. 2009;20:765–776. doi: 10.1681/ASN.2008060566.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2008060566</ArticleId>
            <ArticleId IdType="pmc">PMC2663839</ArticleId>
            <ArticleId IdType="pubmed">19297557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou D, Tan RJ, Zhou L, Li Y, Liu Y. Kidney tubular beta-catenin signaling controls interstitial fibroblast fate via epithelial-mesenchymal communication. Sci Rep. 2013;3:1878. doi: 10.1038/srep01878.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep01878</ArticleId>
            <ArticleId IdType="pmc">PMC3662012</ArticleId>
            <ArticleId IdType="pubmed">23698793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Satoh W, Matsuyama M, Takemura H, Aizawa S, Shimono A. Sfrp1, Sfrp2, and Sfrp5 regulate the Wnt/beta-catenin and the planar cell polarity pathways during early trunk formation in mouse. Genesis. 2008;46:92–103. doi: 10.1002/dvg.20369.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/dvg.20369</ArticleId>
            <ArticleId IdType="pubmed">18257070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuyama M, Nomori A, Nakakuni K, Shimono A, Fukushima M. Secreted Frizzled-related protein 1 (Sfrp1) regulates the progression of renal fibrosis in a mouse model of obstructive nephropathy. J Biol Chem. 2014;289:31526–31533. doi: 10.1074/jbc.M114.584565.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M114.584565</ArticleId>
            <ArticleId IdType="pmc">PMC4223350</ArticleId>
            <ArticleId IdType="pubmed">25253698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xue H, et al.  Disruption of the Dapper3 gene aggravates ureteral obstruction-mediated renal fibrosis by amplifying Wnt/beta-catenin signaling. J Biol Chem. 2013;288:15006–15014. doi: 10.1074/jbc.M113.458448.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M113.458448</ArticleId>
            <ArticleId IdType="pmc">PMC3663521</ArticleId>
            <ArticleId IdType="pubmed">23580654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen B, et al.  Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol. 2009;5:100–107. doi: 10.1038/nchembio.137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nchembio.137</ArticleId>
            <ArticleId IdType="pmc">PMC2628455</ArticleId>
            <ArticleId IdType="pubmed">19125156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palmer HG, et al.  Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol. 2001;154:369–387.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2150773</ArticleId>
            <ArticleId IdType="pubmed">11470825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou L, et al.  Multiple genes of the renin-angiotensin system are novel targets of Wnt/beta-catenin signaling. J Am Soc Nephrol. 2015;26:107–120. doi: 10.1681/ASN.2014010085.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2014010085</ArticleId>
            <ArticleId IdType="pmc">PMC4279741</ArticleId>
            <ArticleId IdType="pubmed">25012166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DiRocco DP, Kobayashi A, Taketo MM, McMahon AP, Humphreys BD. Wnt4/beta-catenin signaling in medullary kidney myofibroblasts. J Am Soc Nephrol. 2013;24:1399–1412. doi: 10.1681/ASN.2012050512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2012050512</ArticleId>
            <ArticleId IdType="pmc">PMC3752942</ArticleId>
            <ArticleId IdType="pubmed">23766539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang P, Cai Y, Soofi A, Dressler GR. Activation of Wnt11 by transforming growth factor-beta drives mesenchymal gene expression through non-canonical Wnt protein signaling in renal epithelial cells. J Biol Chem. 2012;287:21290–21302. doi: 10.1074/jbc.M112.357202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M112.357202</ArticleId>
            <ArticleId IdType="pmc">PMC3375550</ArticleId>
            <ArticleId IdType="pubmed">22556418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kato H, et al.  Wnt/beta-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival. J Biol Chem. 2011;286:26003–26015. doi: 10.1074/jbc.M111.223164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M111.223164</ArticleId>
            <ArticleId IdType="pmc">PMC3138306</ArticleId>
            <ArticleId IdType="pubmed">21613219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dai C, et al.  Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol. 2009;20:1997–2008. doi: 10.1681/ASN.2009010019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2009010019</ArticleId>
            <ArticleId IdType="pmc">PMC2736766</ArticleId>
            <ArticleId IdType="pubmed">19628668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cain JE, Rosenblum ND. Control of mammalian kidney development by the Hedgehog signaling pathway. Pediatr Nephrol. 2011;26:1365–1371. doi: 10.1007/s00467-010-1704-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00467-010-1704-x</ArticleId>
            <ArticleId IdType="pubmed">21161287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mao J, Kim BM, Rajurkar M, Shivdasani RA, McMahon AP. Hedgehog signaling controls mesenchymal growth in the developing mammalian digestive tract. Development. 2010;137:1721–1729. doi: 10.1242/dev.044586.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.044586</ArticleId>
            <ArticleId IdType="pmc">PMC2860252</ArticleId>
            <ArticleId IdType="pubmed">20430747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao E, Chuang PT. Hedgehog signaling: From basic research to clinical applications. J Formos Med Assoc. 2015;114:569–576. doi: 10.1016/j.jfma.2015.01.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jfma.2015.01.005</ArticleId>
            <ArticleId IdType="pubmed">25701396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abidi A. Hedgehog signaling pathway: a novel target for cancer therapy: vismodegib, a promising therapeutic option in treatment of basal cell carcinomas. Indian J Pharmacol. 2014;46:3–12. doi: 10.4103/0253-7613.124884.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0253-7613.124884</ArticleId>
            <ArticleId IdType="pmc">PMC3912804</ArticleId>
            <ArticleId IdType="pubmed">24550577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katoh Y, Katoh M. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med. 2009;9:873–886.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19860666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie J, et al.  Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature. 1998;391:90–92. doi: 10.1038/34201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/34201</ArticleId>
            <ArticleId IdType="pubmed">9422511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bowers M, et al.  Limb anterior-posterior polarity integrates activator and repressor functions of GLI2 as well as GLI3. Dev Biol. 2012;370:110–124. doi: 10.1016/j.ydbio.2012.07.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ydbio.2012.07.017</ArticleId>
            <ArticleId IdType="pmc">PMC3432687</ArticleId>
            <ArticleId IdType="pubmed">22841643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Attanasio M, et al.  Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis. Nat Genet. 2007;39:1018–1024. doi: 10.1038/ng2072.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng2072</ArticleId>
            <ArticleId IdType="pubmed">17618285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li B, et al.  Increased hedgehog signaling in postnatal kidney results in aberrant activation of nephron developmental programs. Hum Mol Genet. 2011;20:4155–4166. doi: 10.1093/hmg/ddr339.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddr339</ArticleId>
            <ArticleId IdType="pmc">PMC3188992</ArticleId>
            <ArticleId IdType="pubmed">21816948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fabian SL, et al.  Hedgehog-Gli pathway activation during kidney fibrosis. Am J Pathol. 2012;180:1441–1453. doi: 10.1016/j.ajpath.2011.12.039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajpath.2011.12.039</ArticleId>
            <ArticleId IdType="pmc">PMC3349903</ArticleId>
            <ArticleId IdType="pubmed">22342522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou D, et al.  Sonic hedgehog is a novel tubule-derived growth factor for interstitial fibroblasts after kidney injury. J Am Soc Nephrol. 2014;25:2187–2200. doi: 10.1681/ASN.2013080893.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2013080893</ArticleId>
            <ArticleId IdType="pmc">PMC4178435</ArticleId>
            <ArticleId IdType="pubmed">24744439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding H, et al.  Sonic hedgehog signaling mediates epithelial-mesenchymal communication and promotes renal fibrosis. J Am Soc Nephrol. 2012;23:801–813. doi: 10.1681/ASN.2011060614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2011060614</ArticleId>
            <ArticleId IdType="pmc">PMC3338290</ArticleId>
            <ArticleId IdType="pubmed">22302193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kramann R, et al.  Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis. J Clin Invest. 2015 doi: 10.1172/JCI74929.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI74929</ArticleId>
            <ArticleId IdType="pmc">PMC4563736</ArticleId>
            <ArticleId IdType="pubmed">26193634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kramann R, et al.  Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell. 2015;16:51–66. doi: 10.1016/j.stem.2014.11.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stem.2014.11.004</ArticleId>
            <ArticleId IdType="pmc">PMC4289444</ArticleId>
            <ArticleId IdType="pubmed">25465115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schneider J, Arraf AA, Grinstein M, Yelin R, Schultheiss TM. Wnt signaling orients the proximal-distal axis of chick kidney nephrons. Development. 2015;142:2686–2695. doi: 10.1242/dev.123968.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.123968</ArticleId>
            <ArticleId IdType="pubmed">26116665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haegebarth A, Clevers H. Wnt signaling, lgr5, and stem cells in the intestine and skin. Am J Pathol. 2009;174:715–721. doi: 10.2353/ajpath.2009.080758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2353/ajpath.2009.080758</ArticleId>
            <ArticleId IdType="pmc">PMC2665733</ArticleId>
            <ArticleId IdType="pubmed">19197002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krausova M, Korinek V. Wnt signaling in adult intestinal stem cells and cancer. Cell Signal. 2014;26:570–579. doi: 10.1016/j.cellsig.2013.11.032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellsig.2013.11.032</ArticleId>
            <ArticleId IdType="pubmed">24308963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vooijs M, Liu Z, Kopan R. Notch: architect, landscaper, and guardian of the intestine. Gastroenterology. 2011;141:448–459. doi: 10.1053/j.gastro.2011.06.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2011.06.003</ArticleId>
            <ArticleId IdType="pmc">PMC4050496</ArticleId>
            <ArticleId IdType="pubmed">21689653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van der Flier LG, Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol. 2009;71:241–260. doi: 10.1146/annurev.physiol.010908.163145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.physiol.010908.163145</ArticleId>
            <ArticleId IdType="pubmed">18808327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao Z, et al.  Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis. Nature medicine. 2016;22:154–162. doi: 10.1038/nm.4035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.4035</ArticleId>
            <ArticleId IdType="pmc">PMC4872630</ArticleId>
            <ArticleId IdType="pubmed">26779814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005;434:843–850. doi: 10.1038/nature03319.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature03319</ArticleId>
            <ArticleId IdType="pubmed">15829953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kramann R, et al.  Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis. The Journal of clinical investigation. 2015;125:2935–2951. doi: 10.1172/JCI74929.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI74929</ArticleId>
            <ArticleId IdType="pmc">PMC4563736</ArticleId>
            <ArticleId IdType="pubmed">26193634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobayashi T, et al.  Expression and function of the Delta-1/Notch-2/Hes-1 pathway during experimental acute kidney injury. Kidney Int. 2008;73:1240–1250. doi: 10.1038/ki.2008.74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2008.74</ArticleId>
            <ArticleId IdType="pubmed">18418349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta S, et al.  Effect of Notch activation on the regenerative response to acute renal failure. Am J Physiol Renal Physiol. 2010;298:F209–215. doi: 10.1152/ajprenal.00451.2009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.00451.2009</ArticleId>
            <ArticleId IdType="pubmed">19828677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walsh DW, et al.  Co-regulation of Gremlin and Notch signalling in diabetic nephropathy. Biochimica et biophysica acta. 2008;1782:10–21. doi: 10.1016/j.bbadis.2007.09.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbadis.2007.09.005</ArticleId>
            <ArticleId IdType="pubmed">17980714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simic D, et al.  Determination of relative Notch1 and gamma-secretase-related gene expression in puromycin-treated microdissected rat kidneys. Gene Expr. 2013;16:39–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24397211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Surendran K, McCaul SP, Simon TC. A role for Wnt-4 in renal fibrosis. Am J Physiol Renal Physiol. 2002;282:F431–441. doi: 10.1152/ajprenal.0009.2001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.0009.2001</ArticleId>
            <ArticleId IdType="pubmed">11832423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuma A, et al.  Role of WNT10A-expressing kidney fibroblasts in acute interstitial nephritis. PLoS One. 2014;9:e103240. doi: 10.1371/journal.pone.0103240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0103240</ArticleId>
            <ArticleId IdType="pmc">PMC4108433</ArticleId>
            <ArticleId IdType="pubmed">25054240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim MK, et al.  The differential expression of TGF-beta1, ILK and wnt signaling inducing epithelial to mesenchymal transition in human renal fibrogenesis: an immunohistochemical study. Int J Clin Exp Pathol. 2013;6:1747–1758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3759481</ArticleId>
            <ArticleId IdType="pubmed">24040439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang D, Dai C, Li Y, Liu Y. Canonical Wnt/beta-catenin signaling mediates transforming growth factor-beta1-driven podocyte injury and proteinuria. Kidney Int. 2011;80:1159–1169. doi: 10.1038/ki.2011.255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.2011.255</ArticleId>
            <ArticleId IdType="pmc">PMC4300105</ArticleId>
            <ArticleId IdType="pubmed">21832980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang L, et al.  Calmodulin-dependent protein kinase II/cAMP response element-binding protein/Wnt/beta-catenin signaling cascade regulates angiotensin II-induced podocyte injury and albuminuria. J Biol Chem. 2013;288:23368–23379. doi: 10.1074/jbc.M113.460394.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M113.460394</ArticleId>
            <ArticleId IdType="pmc">PMC3743506</ArticleId>
            <ArticleId IdType="pubmed">23803607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren S, et al.  LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1. Proc Natl Acad Sci U S A. 2013;110:1440–1445. doi: 10.1073/pnas.1211179110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1211179110</ArticleId>
            <ArticleId IdType="pmc">PMC3557093</ArticleId>
            <ArticleId IdType="pubmed">23302695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hao S, et al.  Targeted inhibition of beta-catenin/CBP signaling ameliorates renal interstitial fibrosis. J Am Soc Nephrol. 2011;22:1642–1653. doi: 10.1681/ASN.2010101079.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2010101079</ArticleId>
            <ArticleId IdType="pmc">PMC3171936</ArticleId>
            <ArticleId IdType="pubmed">21816937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He W, Kang YS, Dai C, Liu Y. Blockade of Wnt/beta-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J Am Soc Nephrol. 2011;22:90–103. doi: 10.1681/ASN.2009121236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2009121236</ArticleId>
            <ArticleId IdType="pmc">PMC3014038</ArticleId>
            <ArticleId IdType="pubmed">21030600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Surendran K, Schiavi S, Hruska KA. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol. 2005;16:2373–2384. doi: 10.1681/ASN.2004110949.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2004110949</ArticleId>
            <ArticleId IdType="pubmed">15944336</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
